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variants.$ $ To$ identify$ the$ putative$ causative$ genes$ that$ are$ perturbed$ by$48"
these$ variants,$ we$ generate$ a$ large$ transcriptome$ dataset$ (9$ diseaseI49"
relevant$cell$types)$and$identify$23,650$cisIeQTL.$ $We$show$that$these$are$50"
determined$ by$ ∼9,720$ regulatory$ modules,$ of$ which$ ∼3,000$ operate$ in$51"




and$ 5,500$ controls$ and$ show$ that$ they$ are$ significantly$ enriched$ in$56"
causative$genes.$ $ $Our$analyses$ indicate$ that$≥10Ifold$ larger$ sample$sizes$57"
will$ be$ required$ to$ demonstrate$ the$ causality$ of$ individual$ genes$ using$58"
standard$burden$tests.$59"
$60"
INTRODUCTION$61" Genome"Wide"Association"Studies"(GWAS)"scan"the"entire"genome"for"statistical"62" associations"between"common"variants"and"disease"status" in" large"caseAcontrol"63" cohorts.""GWAS"have"identified"tens"to"hundreds"of"risk"loci"for"nearly"all"studied"64" common"complex"diseases"of"human1.""The"study"of"Inflammatory"Bowel"Disease"65" (IBD)"has"been"particularly" successful,"with"more" than"200" confirmed" risk" loci"66" reported"to"date2,3."""As"a"result"of"the"linkage"disequilibrium"(LD)"patterns"in"the"67" human"genome"(limiting"the"mapping"resolution"of"association"studies),"GWASA68" identified"risk"loci"typically"span"~!250"kilobases,"encompassing"an"average"of"~"69" 5" genes" (numbers" ranging" from" zero" (“gene" deserts”)" to" more" than" 50)" and"70" hundreds" of" associated" variants." " Contrary" to" widespread" misconception," the"71"
causative" variants" and" genes" remain" unknown" for" the" vast"majority" of" GWASA72" identified" risk" loci." " Yet," this" remains" a" critical" goal" in" order" to" reap" the" full"73" benefits" of" GWAS" in" identifying" new" drug" targets" and" developing" effective"74" predictive"and"diagnostic"tools.""It"is"the"main"objective"of"postAGWAS"studies."75" Distinguishing" the" few" causative" variants" (i.e." the" variants" that" are" directly"76" causing" the" gene" perturbation)" from" the" many" neutral" variants" that" are" only"77"
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associated"with"the"disease"because"they"are"in"LD"with"the"former"in"the"studied"78" population," requires" the" use" of" sophisticated" fineAmapping"methods" applied" to"79" very" large," densely" genotyped" datasets4," ideally" followedAup" by" functional"80" studies5." " " "Using"such"approaches,"18"causative"variants" for" IBD"were"recently"81" fineAmapped"at"single"base"pair"resolution,"and"51"additional"ones"at"≤"10"base"82" pair"resolution4.""""83" A" minority" of" causative" variants" are" coding," i.e." they" alter" the" aminoAacid"84" sequence"of"the"encoded"protein.""In"such"cases,"and"particularly"if"multiple"such"85" causative" coding" variants" are" found" in" the" same" gene" (i.e." in" case" of" allelic"86" heterogeneity)," the" corresponding" causative" gene" is" unambiguously" identified.""87" In"the"case"of"IBD,"causative"genes"have"been"identified"for"~"ten"risk"loci"on"the"88" basis"of"such"“independently”"(i.e."not"merely"reflecting"LD"with"other"variants)"89" associated" coding" variants," including"NOD2,"ATG16L1," IL23R,"CARD9,'FUT2'and'90"
TYK2'4,6A9."""91" For"the"majority"of"risk"loci,"the"GWAS"signals"are"not"driven"by"coding"variants.""92" They"must"therefore"be"driven"by"common"regulatory"variants,"i.e."variants"that"93" perturb" the" expression" levels" of" one" (or"more)" target" genes" in" one" (or"more)"94" disease"relevant"cell"types4.""Merely"reflecting"the"proportionate"sequence"space"95" that" is" devoted" to" the" different" layers" of" gene" regulation" (transcriptional,"96" posttranscriptional," translational," posttranslational)," the"majority" of" regulatory"97" variants" are" likely" to" perturb" components" of" “gene" switches”" (promoters,"98" enhancers," insulators)," hence" affecting" transcriptional" output." " " Indeed," fineA99" mapped"nonAcoding"variants"are"enriched"in"known"transcriptionAfactor"binding"100" sites"and"epigenetic" signatures"marking"gene"switch"components4." " "Hence," the"101" majority" of" common" causative" variants" underlying" inherited" predisposition" to"102" common" complex" diseases" must" drive" cisAeQTL" (expression" quantitative" trait"103" loci)" affecting" the" causative"gene(s)" in"one"or"more"disease" relevant" cell" types."104" The"corresponding"cisAeQTL"are"expected"to"operate"prior"to"disease"onset,"and"–"105" driven" by" common" variants" –" detectable" in" cohorts" of" healthy" individuals" of"106" which"most"will"never"develop"the"disease."""The"term"cisAeQTL"refers"to"the"fact"107" that" the" regulatory" variants" that" drive" them" only" affect" the" expression" of"108" genes/alleles" residing" on" the" same" DNA"molecule," typically" no"more" than" one"109" megabase" away." Causative" variants," whether" coding" or" regulatory," may"110"
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secondarily" perturb" the" expression" of" genes/alleles" located" on" different" DNA"111" molecules,"generating"transAeQTL."Some"of"these"transAeQTL"may"participate" in"112" the"disease"process.""""""""""""""113" CisAeQTL" effects" are" known" to" be" very" common," affecting" more" than" 50%" of"114" genes10." " Hence," finding" that" variants" associated" with" a" disease" are" also"115" associated" with" changes" in" expression" levels" of" a" neighboring" gene" is" not"116" sufficient"to"incriminate"the"corresponding"genes"as"causative."""""Firstly,"one"has"117" to" show" that" the" local" association" signal" for" the" disease" and" for" the" eQTL" are"118" driven" by" the" same" causative" variants." " " A" variety" of" “colocalisation”"methods"119" have"been"developed"to"that"effect11A13.""Secondly,"regulatory"variants"may"affect"120" elements" that" control" the" expression" of" multiple" genes14," which" may" not" all"121" contribute"to"the"development"of"the"disease,"i.e."be"causative."""Thus,"additional"122" evidence"is"needed"to"obtain"formal"proof"of"gene"causality."""In"humans,"the"only"123" formal"test"of"gene"causality"that"is"applicable"is"the"family"of"“burden”"tests,"i.e."124" the"search"for"a"differential"burden"of"disruptive"mutations"in"cases"and"controls,"125" which" is" expected" only" for" causative" genes15." " Burden" tests" rely" on" the"126" assumption" that" –" in" addition" to" the" common,"mostly" regulatory" variants" that"127" drive"the"GWAS"signal"–"the"causative"gene"will"be"affected"by"low"frequency"and"128" rare"causative"variants,"including"coding"variants."""Thus,"the"burden"test"makes"129" the"assumption"that"allelic"heterogeneity"is"common,"which"is"supported"by"the"130" pervasiveness" of" allelic" heterogeneity" of" Mendelian" diseases" in" humans16."""131" Burden"tests"compare"the"distribution"of"rare"coding"variants"between"cases"and"132" controls15." " " The" signalAtoAnoise" ratio" of" the" burden" test" can" be" increased" by"133" restricting" the" analysis" to" coding" variants" that" have" a" higher" probability" to"134" disrupt"protein"function15." " " " In"the"case"of"IBD,"burden"tests"have"been"used"to"135" prove"the"causality"of"NOD2,"IL23R"and"CARD96,8,9." " "A"distinct"and"very"elegant"136" genetic"test"of"gene"causality"is"the"reciprocal"hemizygosity"test,"and"the"related"137" quantitative" complementation"assay17,18." " "However,"with" few"exceptions19,20," it"138" has" only" been" applied" in" model" organisms" in" which" gene" knockAouts" can" be"139" readily"generated21.""140" In" this" paper,"we"describe" the" generation" of" a" new"and" large" dataset" for" eQTL"141" analysis"(350"healthy"individuals)"in"nine"cell"types"that"are"potentially"relevant"142" for"IBD.""We"identify"and"characterize"~24,000"cisAeQTL.""By"comparing"disease"143"
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and"eQTL"association"patterns"using"a"newly"developed"statistic,"we"identify"99"144" strong" positional" candidate" genes" in" 63" GWASAidentified" risk" loci." " " We"145" resequence"the"555"exons"of"45"of"these"in"6,600"cases"and"5,500"controls"in"an"146" attempt"to"prove"their"causality"by"means"of"burden"tests." "The"outcome"of"this"147" study" is" relevant" to" postAGWAS" studies" of" all" common" complex" disease" in"148" humans."""""""149" """""""""""""""""""""""150"
RESULTS$151"
Clustering+cis-eQTL+into+regulatory+modules+152" We"generated"transcriptome"data"for"six"circulating"immune"cell"types"(CD4+"T"153" lymphocytes," CD8+" T" lymphocytes," CD19+" B" lymphocytes," CD14+" monocytes,"154" CD15+"granulocytes,"platelets)"as"well"as"ileal,"colonic"and"rectal"biopsies"(IL,"TR,"155" RE),"collected"from"323"healthy"Europeans"(141"men,"182"women,"average"age"156" 56" years," visiting" the" clinic" as" part" of" a" national" screening" campaign" for" colon"157" cancer)" using" Illumina" HT12" arrays" (CEDAR" dataset;" Methods)." " IBD" being"158" defined"as"an" inappropriate"mucosal" immune"response"to"a"normal"commensal"159" gut"flora22,"these"nine"cell"types"can"all"be"considered"to"be"potentially"diseaseA160" relevant.""Using"standard"methods"based"on"linear"regression"and"one"megabase"161" windows" centered" on" the" position" of" the" interrogating" probe" (Methods)," we"162" identified" significant" cisAeQTL" (FDR" <" 0.05)" for" 8,804" of" 18,580" tested" probes"163" (corresponding"to"7,216"of"13,615"tested"genes)"in"at"least"one"tissue,"amounting"164" to"a"total"of"23,650"cisAeQTL"effects"(Supplementary"Data"1).""When"a"gene"shows"165" a" cisAeQTL" in" more" than" one" tissue," the" corresponding" “eQTL" association"166" patterns”" (EAP)" (i.e." the" distribution" of" association" Rlog(p)" values" for" all" the"167" variants"in"the"region"of"interest)"are"expected"to"be"similar"if"determined"by"the"168" same" regulatory" variants," and" dissimilar" otherwise." " Likewise," if" several"169" neighboring" genes" show" cisAeQTL" in" the" same" or" distinct" tissues," the"170" corresponding" EAP" are" expected" to" be" similar" if" determined" by" the" same"171" regulatory"variants,"and"dissimilar"otherwise"(Fig."1)." " "We"devised"the"ϑ"metric"172" to" measure" the" similarity" between" association" patterns" (Methods)." ϑ" is" a"173" correlation"measure" for"paired" Rlog(p)" values" (for" the" two"eQTL" that" are"being"174" compared)" that" ranges" between" A1" and" +1." "! "shrinks" to" zero" if" Pearson’s"175"
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correlation"between"paired"Rlog(p)"values"does"not"exceed"a"chosen"threshold"(i.e."176" if"the"EAP"are"not"similar)." "ϑ"approaches"+1"when"the"two"EAP"are"similar"and"177" when" variants" that" increase" expression" in" eQTL" 1" consistently" increase"178" expression"in"eQTL"2.""ϑ"approaches"A1"when"the"two"EAP"are"similar"and"when"179" variants"that"increase"expression"in"eQTL"1"consistently"decrease"expression"in"180" eQTL"2." "!"gives"more"weight" to"variants"with"high" Rlog(p)" for"at" least"one"EAP"181" (i.e."it"gives"more"weight"to"eQTL"peaks)."""Based"on"the"known"distribution"of"ϑ"182" under"H0"(i.e."eQTL"determined"by"distinct"variants" in" the"same"region)"and"H1"183" (i.e." eQTL" determined" by" the" same" variants)," we" selected" a" threshold" value"184" ! > 0.60"to"consider"that"two"EAP"were"determined"by"the"same"variant.""This"185" corresponds" to" a" false" positive" rate" of" 0.05," and" a" false" negative" rate" of" 0.23"186" (Supplementary"Fig."1).""""We"then"grouped"EAP"in"“cisAacting"regulatory"modules”"187" (cRM)"using" ! "and"a"singleAlink"clustering"approach"(i.e."an"EAP"needs"to"have"188" ! > 0.60"with"at"least"one"member"of"the"cluster"to"be"assigned"to"that"cluster)."""189" Clusters" were" visually" examined" and" 29" single" edges" connecting" otherwise"190" unlinked"and"yet"tight"clusters"manually"removed"(Supplementary"Fig."2)."""""""""""""""191" Using" this" approach," we" clustered" the" 23,650" effects" in" 9,720" distinct" “cisA192" regulatory" modules”" (cRM)," encompassing" cisAeQTL" with" similar" EAP"193" (Supplementary" Data" 2)." " " SixtyAeight" percent" of" cRM" were" geneA" and" tissueA194" specific," 22%" were" geneAspecific" but" operating" across" multiple" tissues" (≤9"195" tissues," average" 3.5)," and" 10%"were"multiAgenic" (≤11" genes," average" 2.5)" and"196" nearly" always" multiAtissue" (Fig." 2&3," Supplementary" Fig." 2)." " In" this," cRM" are"197" considered" geneAspecific" if" the" EAPs" in" the" cluster" concern" only" one" gene," and"198" tissueAspecific" if" the"EAP" in" the"cluster" concern"only"one"of" the"nine"cell" types.""199" They" are," respectively," multigenic" and" multiAtissue" otherwise." " cRM" operating"200" across"multiple" tissues" tended" to" affect"multiple" genes" (r" =" 0.47;" p" <" 10A6)." " In"201" such"cRM,"the"direction"of"the"effects"tended"to"be"consistent"across"tissues"and"202" genes" (p" <" 10A6)." " Nevertheless," we" observed" at" least" 55" probes"with" effect" of"203" opposite"sign"in"distinct"cell"types"(! ≤ −0.9)," i.e."the"corresponding"regulatory"204" variants" increases" transcript" levels" in" one" cell" type" while" decreasing" them" in"205" another"(Fig."4"and"Supplementary"Data"3)." " " "Individual"tissues"allowed"for"the"206" detection" of" 7" to" 33%" of" all" cRM," and" contributed" 3" to" 14%" unique" cRM"207" (Supplementary"Fig."3).""SixtyAnine"percent"of"cRM"were"only"detected"in"one"cell"208"
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type." The" rate" of" cRM" sharing" between" cell" types" reflects" known" ontogenic"209" relations." " Considering" cRM" shared" by" only" two" cell" types" (i.e." what" jointly"210" differentiates"these"two"cell"types"from"all"other),"revealed"the"close"proximity"of"211" the" CD4ACD8," CD14ACD15," ileumAcolon," and" colonArectum" pairs." " Adding"212" information"of"cRM"shared"by"up"to"six"cell"types"grouped"lymphoid"(CD4,"CD8,"213" CD19),"myeloid"(CD14,"CD15"but"not"platelets),"and"intestinal"(ileum,"colon"and"214" rectum)" cells." " Adding" cRM"with" up" to" nine" cell" types" revealed" a" link" between"215" ileum"and"blood"cells,"possibly"reflecting"the"presence"of"blood"cells" in"the"ileal"216" biopsies"(Fig."5)."+217"
cRM+matching+IBD+association+signals+are+often+multigenic+218" If" regulatory" variants" affect" disease" risk" by" perturbing" gene" expression," the"219" corresponding"“disease"association"patterns”"(DAP)"and"EAP"are"expected"to"be"220" similar," even" if" obtained" in" distinct" cohorts" (yet" with" same" ethnicity)" (Fig." 6)."""221" We" confronted" DAP" and" EAP" using" the" ϑ" statistic" and" threshold" ( ! > 0.60)"222" described"above"for"200"GWASAidentified"IBD"risk"loci."DAP"for"Crohn’s"disease"223" and" Ulcerative" Colitis" were" obtained" from" the" International" IBD" Genetics"224" Consortium"(IIBDGC)2,3,"EAP"from"the"CEDAR"dataset."225" The"probability"that"two"unrelated"association"signals"in"a"chromosome"region"of"226" interest"are"similar"(i.e."have"high" ! "value)"is"affected"by"the"degree"of"LD"in"the"227" region.""If"the"LD"is"high"it"is"more"likely"that"two"association"signals"are"similar"228" by" chance." " To" account" for" this," we" generated" EAPA" and" locusAspecific"229" distributions" of" ! "by" simulating" eQTL" explaining" the" same" variance" as" the"230" studied"eQTL,"yet"driven"by"100"variants"that"were"randomly"selected"in"the"risk"231" locus"(matched"for"MAF),"and"computing" ! "with"the"DAP"for"all"of"these." " "The"232" resulting" empirical" distribution" of" ! "was" used" to" compute" the" probability" to"233" obtain" a" value" of" ! "as" high" or" higher" than" the" observed" one," by" chance" alone"234" (Methods)."""""""""""""""""235" Strong" correlations" between" DAP" and" EAP" ( ! !> 0.6 ," associated" with" low"236" empirical" pAvalues)" were" observed" for" at" least" 63" IBD" risk" loci," involving" 99"237" genes"(range"per"locus:"1A6)"(Table"1,"Fig."7,"Supplementary"Data"4)." "Increased"238" disease"risk"was"associated"equally"frequently"with"increased"as"with"decreased"239" expression"(pCD"="0.48;"pUC"="0.88)." "An"openAaccess"website"has"been"prepared"240"
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to" visualize" correlated" DAPAEAP" within" their" genomic" context" (http://cedarA241" web.giga.ulg.ac.be)." " " Genes" with" highest" ! "values" (≥" 0.9)" include" known" IBD"242" causative" genes" (f.i." ATG16L1," CARD9,' FUT2)," known" immune" regulators" (f.i."243"
IL18R1,'IL6ST,'THEMIS),"as"well"as"genes"with"as"of"yet"poorly"defined"function"in"244" the" context" of" IBD" (f.i." APEH," ANKRD55," CISD1,' CPEB4,' DOCK7,' ERAP2,' GNA12,'245"
GPX1,'GSDMB,'ORMDL3,'SKAP2,'UBE2L3,'ZMIZ1)"(Supplementary"Note"1)."""246" The"eQTL" link"with" IBD"has"not"been" reported"before" for" at" least"47"of" the"99"247" reported"genes"(Table"1).""eQTL"links"with"IBD"have"been"previously"reported"for"248" 111"additional"genes,"not"mentioned"in"Table"1.""Our"data"support"these"links"for"249" 19"of"them,"however,"with" ! ≤ 0.6"(Supplementary"Data"5)."""We"applied"SMR13"250" as"alternative"colocalisation"method"to"our"data." " "Using"a"BonferroniAcorrected"251" threshold"of"≤!2.5"x"10A5"for"pSMR"and"≥"0.05"for"pHEIDI,"SMR"detected"35"of"the"99"252" genes"selected"with"!"(Supplementary"Data"4).""Using"the"same"thresholds,"SMR"253" detected" nine" genes" that" were" not" selected" by"!." " " Of" these," three" (ADAM15,"254"
AHSA2," UBA7)" had" previously" been" reported" by" others," while" six" (FAM189B,'255"
QRICH1,'RBM6,'TAP2,'ADO,'LGALS9)"were"not." "Of" these"six," three"(RBM6,"TAP2,"256"
ADO)"were"characterized"by"0.45 < ! < 0.6"(Supplementary"Data"5).""257" Using" an" early" version" of" the" CEDAR" dataset," significant" (albeit" modest)"258" enrichment"of"overlapping"disease"and"eQTL"signals"was"reported"for"CD4,"ileum,"259" colon" and" rectum," focusing" on" 76" of" 97" studied" IBD" risk" loci" (MAF" of" disease"260" variant" >" 0.05)4." " " By" preAcorrecting" fluorescence" intensities" with" 23" to" 53"261" (depending" on" cell" type)" principal" components" to" account" for" unidentified"262" confounders"(Methods),"we"increased"the"number"of"significant"eQTL"from"480"263" to"880"in"the"corresponding"97"regions"(11,964"to"23,650"for"the"whole"genome).""""264" We"repeated"the"enrichment"analysis"focusing"on"63"of"the"same"97"IBD"loci"(CD"265" risk" loci;" MAF" of" disease" variant" >" 0.05)," using" three" colocalisation" methods"266" including"!"(Methods)."""We"observed"a"systematic"excess"overlap"in"all"analyzed"267" cell" types" (2.5Afold"on"average)." " The" enrichment"was"very" significant"with" the"268" three"methods"in"CD4"and"CD8"(Supplementary"Table"1)."""""""269" The"400"analyzed"DAP"(200"CD"and"200"UC)"were"found"to"match"76"cRM"(in"63"270" risk" loci)"with" ! !> 0.6"(Table"1)," of"which"25"are"multigenic." " " "Knowing" that"271" multigenic" cRM" represent" 10%" of" all" cRM" (967/9,720)," 25/76" (i.e." 33%)"272"
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corresponds"to"a"highly"significant"3Afold"enrichment"(p"<"10A9).""To"ensure"that"273" this"apparent"enrichment"was"not"due"to"the"fact"that"multigenic"cRM"have"more"274" chance" to"match" DAP" (as" by" definition"multiple" EAP" are" tested" for"multigenic"275" cRM)," we" repeated" the" enrichment" analysis" by" randomly" sampling" only" one"276" representative"EAP"per"cRM"in"the"200"IBD"risk"loci.""The"frequency"of"multigenic"277" cRM" amongst" DAPAmatching" cRM" averaged" 0.22," and" was" never" ≤ 0.10"278" (!! ≤ 10!!)"(Supplementary"Fig."4).""In"loci"with"high"LD,"EAP"driven"by"distinct"279" regulatory"variants"(yet"in"high"LD)"may"erroneously"be"merged"in"the"same"cRM.""280" To"ensure"that"the"observed"enrichment"in"multigenic"cRM"was"not"due"to"higher"281" levels" of" LD," we" compared" the" LDAbased" recombination" rate" of" the" 63" cRMA282" matching" IBD" risk" loci" with" that" of" the" rest" of" the" genome23." " " The" genomeA283" average"recombination"rate"was"1.23"centimorgan"per"megabase"(cM/Mb),"while"284" that"of"the"63"IBD"risk"loci"was"1.34"cM/Mb,"i.e."less"LD"in"the"63"cRMAmatching"285" IBD"risk" loci" than"in"the"rest"of"the"genome." "We"further"compared"the"average"286" recombination"rate" in" the"63"cRMAmatching" IBD"regions"with"that"of"sets"of"63"287" loci"centered"on"randomly"drawn"cRM"(from"the"list"of"9,720),"matched"for"size"288" and" chromosome" number" (as" cM/Mb" is" affected" by" chromosome" size)." " " The"289" average" recombination" rate" around" all" cRM" was" 1.43" cM/Mb," and" this" didn’t"290" differ" significantly" from" the" 63" cRMAmatching" IBD" regions" (p=0.46)"291" (Supplementary" Fig." 5)." " Therefore," the" observed" enrichment" cannot" be"292" explained"by" a"higher"LD" in" the"63" studied" IBD" risk" loci." " Taken" together,"EAP"293" that" are" strongly" correlated"with"DAP" ( ! ≥ 0.60),"map" to" regulatory"modules"294" that"are!2A"to"3Afold"enriched"in"multigenic"cRM"when"compared"to"the"genome"295" average" and" include" four" of" the" top" 10" (of" 9,720)" cRM" ranked" by" number" of"296" affected"genes."297"
DAP-matching+cRM+are+enriched+in+causative+genes+for+IBD+298" For" truly"causative"genes," the"burden"of" rare"disruptive"variants" is"expected" to"299" differ" between" cases" and" controls24." " We" therefore" performed" targeted"300" sequencing" for" the" 555" coding" exons" (∼88" Kb)" of" 38" genes" selected" amongst"301" those" with" strongest" DAPAEAP" correlations," plus" seven" genes" with" suggestive"302" DAPAEAP"evidence"backed"by" literature" (Table"1)," in" 6,597"European"CD" cases"303" and"5,502"matched"controls"(ref."25"and"Methods)."""Eighteen"of"these"were"part"304" of"singleAgene"cRM"and"the"only"gene"highlighted"in"the"corresponding"locus."The"305"
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remaining" 27" corresponded" to" multiAgene" cRM" mapping" to" 15" risk" loci." " We"306" added" the" wellAestablished" NOD2" and" IL23R" causative" IBD" genes" as" positive"307" controls." We" identified" a" total" of" 174" lossAofAfunction" (LoF)" variants," 2,567"308" missense" variants" (of" which" 991" predicted" by" SIFT26" to" be" damaging" and"309" PolyphenA227" to" be" either" possibly" or" probably" damaging)," and" 1,434"310" synonymous" variants" (Fig." 8" and" Supplementary" Data" 6)." 1,781" of" these"were"311" also"reported"in"the"Genome"Aggregation"Database28"with"nearly"identical"allelic"312" frequencies" (Supplementary" Fig." 6)."We" designed" a" geneAbased" burden" test" to"313" simultaneously"evaluate"hypothesis"(i):"all"disruptive"variants"enriched"in"cases"314" (when"ϑ"<"0;"risk"variants)"or"all"disruptive"variants"enriched"in"controls"(when"ϑ"315" >"0;"protective"variants),"and"hypothesis"(ii):"some"disruptive"variants"enriched"316" in" cases" and" others" in" controls." " Hypothesis" (i)" was" tested" with" CAST29," and"317" hypothesis"(ii)"with"SKAT30"(Methods)." "We"restricted"the"analysis"to"1,141"LoF"318" and"damaging"missense"variants"with"minor"allele" frequency" (MAF)"≤"0.005" to"319" ensure"that"any"new"association"signal"would"be"independent"of"the"signals"from"320" common"and" low" frequency"variants"having" led" to" the" initial" identification"and"321" fineAmapping"of"the"corresponding"loci4.""For"NOD2"(p"="6.9"x"10A7)"and"IL23R"(p"322" =" 1.8" x" 10A4)," LoF" and" damaging" variants" were" significantly" enriched" in"323" respectively" cases" and" controls" as" expected." " When" considering" the" 45" newly"324" tested"genes"as"a"whole,"we"observed"a"significant"(p"="6.9"x"10A4)"shift"towards"325" lower" pAvalues" when" compared" to" expectation," while" synonymous" variants"326" behaved"as"expected"(p"="0.66)"(Fig."9"and"Supplementary"Data"7).""This"strongly"327" suggests" that" the" sequenced" list" includes" causative" genes." " " CARD9," TYK2" and"328"
FUT2" have" recently" been" shown" to" be" causative" genes" based" on" diseaseA329" associated" lowAfrequency" coding" variants" (MAF" >" 0.005)4." The" shift" towards"330" lower" pAvalues" remained" significant" without" these" (p" =" 1.7" x" 10A3)," pointing"331" towards"novel"causative"genes"amongst"the"42"remaining"candidate"genes.""332"
Proving+gene+causality+requires+larger+case-control+cohorts."333" Despite" the" significant" shift" towards" lower" pAvalues" when" considering" the" 45"334" genes" jointly," none" of" these" were" individually" significant" when" accounting" for"335" multiple" testing" (! ≤ !.!"!∗!" ≈ 0.0006)" (Supplemental" Data" 7)." " Near" identical"336" results"were"obtained"when"classifying"variants"using"the"Combined"Annotation"337"
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Dependent"Depletion"(CADD)"tool31"instead"of"SIFT/PolyPhenA2"(Supplementary"338" Data"7).""We"explored"three"approaches"to"increase"the"power"of"the"burden"test.""339" The" first" built" on" the" observation" that" cRM" matching" DAP" are" enriched" in"340" multigenic"modules."""This"suggests"that"part"of"IBD"risk"loci"harbor"multiple"coA341" regulated"and"hence"functionally"related"genes,"of"which"several"(rather"than"one,"342" as"generally"assumed)"may"be"causally" involved" in"disease"predisposition." " "To"343" test"this"hypothesis,"we"designed"a"moduleA"rather"than"geneAbased"burden"test"344" (Methods)." " "However,"none"of" the"30" tested"modules" reached" the"experimentA345" wide" significance" threshold" (! ≤ !.!"!∗!" ≈ 0.0008)." " " Moreover," the" shift" towards"346" lower" pAvalues" for" the" 30" modules" was" not" more" significant" (! = 2.3!!!10!!)"347" than"for"the"geneAbased"test"(Supplementary"Fig."7A"and"Supplementary"Table"7).""348" The"second"and"third"approaches"derive"from"the"common"assumption"that"the"349" heritability" of" disease" predisposition"may" be" larger" in" familial" and" earlyAonset"350" cases32." " We" devised" orthogonal" tests" for" ageAofAonset" and" familiality" and"351" combined" them" with" our" burden" tests" (Methods)." " " Neither" approach" would"352" improve"the"results"(Supplementary"Fig."7B&C"and"Supplementary"Data"7).""""""""""""""""353" Assuming"that"TYK2"and"CARD9"are"truly"causative"and"their"effect"sizes"in"our"354" data" unbiased,"we" estimated" that" a" caseAcontrol" cohort" ranging" from"~"50,000"355" (TYK2)" to"~200,000" (CARD9)" individuals" would" have" been" needed" to" achieve"356" experimentAwide" significance" (testing" 45" candidate" genes)," and" from"~!78,000"357" (TYK2)" to" >500,000" (CARD9)" individuals" to" achieve" genomeAwide" significance"358" (testing"20,000"genes)"in"the"geneAbased"burden"test"(Supplementary"Fig."8)."""""""359"
$360"
DISCUSSION$$$361" We"herein"describe"a"novel"dataset"comprising"arrayAbased"transcriptome"data"362" for" six" circulating" immune" cell" types" and" intestinal" biopsies" at" three" locations"363" collected"on"∼300"healthy"European" individuals." " " "We"use" this"CEDAR"dataset"364" (“Correlated" Expression" and"Disease" Association" Research”)" to" identify" 23,650"365" significant" cisAeQTL,"which" fall" into"9,720" regulatory"modules"of"which"at" least"366"
∼889" affect"more" than" one" gene" in"more" than" one" tissue." " "We" provide" strong"367" evidence"that"63"of"200"known"IBD"GWAS"signals"reflect"the"activity"of"common"368"
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regulatory"variants" that"preferentially"drive"multigenic"modules." " "We"perform"369" an"exonAbased"burden"test" for"45"positional"candidate"CD"genes"mapping"to"33"370" modules,"in"5,500"CD"cases"and"6,500"controls.""""By"demonstrating"a"significant"371" (! = 6.9!!!10!!)"upwards"shift"of"log(1/p)"values"for"damaging"when"compared"372" to" synonymous" variants," we" show" that" the" sequenced" genes" include" new"373" causative"CD"genes."""374" Individually," none" of" the" sequenced" genes" (other" than" the" positive"NOD2" and"375"
IL23R" controls)" exceed" the" experimentAwide" significance" threshold," precluding"376" us" from"definitively"pinpointing"any"novel"causative"genes." " "However,"we"note"377"
IL18R1'amongst"the"topAranking"genes"(see"also"Supplementary"Note"1)."""IL18R1"378" is"the"only"gene"in"an"otherwise"relatively"geneApoor"region"(also"encompassing"379"
IL1R1" and" IL18RAP)"characterized"by"robust"cisAeQTL" in"CD4"and"CD8" that"are"380" strongly"correlated"with"the"DAP"for"CD"and"UC"(0.68! ≤ ! ! ≤ 0.93)."" "Reduced"381" transcript"levels"of"IL18R1"in"these"cell"types"is"associated"with"increased"risk"for"382" IBD." " Accordingly," rare" (MAF"≤"0.005)" damaging" variants" were" cumulatively"383" enriched"in"CD"cases"(CAST"p"="0.05).""""The"cumulative"allelic"frequency"of"rare"384" damaging" variants"was" found" to"be"higher" in" familial" CD" cases" (0.0027),"when"385" compared"to"nonAfamilial"CD"cases"(0.0016;"p"="0.09)"and"controls"(0.0010;"p"="386" 0.03)." " "When" ignoring"carriers"of"deleterious"NOD2"mutations,"average"ageAofA387" onset"was"reduced"by"∼3"years"(25.3"vs"28.2"years)"for"carriers"of"rare"damaging"388"
IL18R1"variants"but"this"difference"was"not"significant"(p"="0.18).""389" While" the" identification" of" matching" cRM" for" 63/200" DAP" points" towards" a"390" number" of" strong" candidate" causative" genes," it" leaves" most" risk" loci" without"391" matching" eQTL" despite" the" analysis" of" nine" diseaseArelevant" cell" types." " This"392" finding" is" in" agreement" with" previous" reports4,33." " It" suggests" that" cisAeQTL"393" underlying"disease"predisposition"operate"in"cell"types,"cell"states"(f.i."resting"vs"394" activated)" or" developmental" stages" that" were" not" explored" in" this" and" other"395" studies." " " It" calls" for" the" enlargement" and" extension" of" eQTL" studies" to" more"396" diverse" and" granular" cellular" panels10,34," possibly" by" including" singleAcell"397" sequencing"or"spatial"transcriptomic"approaches.""By"performing"eQTL"studies"in"398" a" cohort" of" healthy" individuals,"we"have"made" the" reasonable" assumption" that"399" the" common" regulatory" variants" that" are"driving" the"majority" of"GWAS" signals"400" are"acting"before"disease"onset," including"in" individuals"that"will"never"develop"401"
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the" disease." " An" added" advantage" of" studying" a" healthy" cohort," is" that" the"402" corresponding"dataset" is"“generic”,"usable"for"the"study"of"perturbation"of"gene"403" regulation" for" any" common" complex" disease." " However," it" is" conceivable" that"404" some"eQTL"underlying"increased"disease"risk"only"manifest"themselves"once"the"405" disease"process" is" initiated," for" instance"as"a" result"of"a"modified" inflammatory"406" status." " "Thus," it"may"be"useful" to"perform"eQTL"studies"with"samples"collected"407" from" affected" individuals" to" see" in" how" far" the" eQTL" landscape" is" affected" by"408" disease"status.""""""409" One" of" the"most" striking" results" of" this"work" is" the" observation" that" cRM" that"410" match" DAP" are"≥2Afold" enriched" in" multiAgenic" modules." " " We" cannot" fully"411" exclude"that"this" is"due"to"ascertainment"bias." " "As"multiAgenic"modules"tend"to"412" also"be"multiAtissue,"multiAgenic"cRM"matching"a"DAP"in"a"nonAexplored"diseaseA413" relevant" cell" type"have" a" higher"probability" to" be"detected" in" the" explored" cell"414" types" than" the"equivalent"monogenic" (and"hence"more" likely" cell" type"specific)"415" cRM.""The"alternative"explanation"is"that"cRM"matching"DAP"are"truly"enriched"in"416" multiAgenic" cRM." " It" is" tempting" to" surmise" that" loci" harboring" clusters" of" coA417" regulated," functionally" related" causative" genes" have" a" higher" probability" to" be"418" detected" in" GWAS," reflecting" a" relatively" larger" target" space" for" causative"419" mutations." " "We"herein"tested"this"hypothesis"by"applying"a"module"rather"than"420" geneAbased" test." " Although" this" did" not" appear" to" increase" the" power" of" the"421" burden" test" in" this"work," it" remains" a" valuable" approach" to" explore" in" further"422" studies." " Supplementary" Data" 2" provides" a" list" of" >900" multigenic" modules"423" detected"in"this"work"that"could"be"used"in"this"context."""""""""""""""""""""""""""""""""424" Although"we"reAsequenced"the"ORF"of"45"carefully"selected"candidate"genes"in"a"425" total"of"5,500"CD"cases"and"6,600"controls,"none"of"the"tested"genes"exceeded"the"426" experimentAwide"threshold"of"significance."""This"is"despite"the"fact"that"we"used"427" a"oneAsided,"eQTLAinformed"test"to"potentially"increase"power." "Established"IBD"428" causative" genes" used" as" positive" control," NOD2" and" IL23R," were" positive"429" indicating" that" the" experiment"was"properly" conducted." " "We"were"not" able" to"430" improve" the" signal" strength" by" considering" information" about" regulatory"431" modules," familiality"or"ageAofAonset." "We"estimated"that"≥10Afold" larger"sample"432" sizes" will" be" needed" to" achieve" adequate" power" if" using" the" same" approach."433"
Momozawa'et'al.'' ' Page'14'of'45'
Although" challenging," these" numbers" are" potentially" within" reach" of"434" international"consortia"for"several"common"diseases"including"IBD."""435" It"is"conceivable"that"the"organAspecificity"of"nearly"all"complex"diseases"(such"as"436" the" digestive" tract" for" IBD)," reflects" tissueAspecific" perturbation" of" broadly"437" expressed"causative"genes"that"may"fulfill"diverse" functions" in"different"organs."""438" If" this" is" true,"coding"variants"may"not"be"the"appropriate"substrate"to"perform"439" burden"tests,"as"these"will"affect"the"gene"across"all" tissues." " " In"such"instances,"440" the"disruptive"variants"of" interest"may"be" those"perturbing" tissueAspecific"gene"441" switches.""Also,"it"has"recently"been"proposed"that"the"extreme"polygenic"nature"442" of"common"complex"diseases"may"reflect"the"transAeffects"of"a" large"proportion"443" of" regulatory" variants" active" in" a" given" cell" type" on" a" limited" number" of" core"444" genes" via" perturbation" of" highly" connected" gene" networks35." " Identifying" rare"445" regulatory"variants"is"still"challenging,"however,"as"tissueAspecific"gene"switches"446" remain"poorly"catalogued,"and"the"effect"of"variants"on"their"function"difficult"to"447" predict." " "The"corresponding"sequence"space"may"also"be" limited" in"size,"hence"448" limiting" power." " Nevertheless," a" reasonable" start" may" be" to" reAsequence" the"449" regions"surrounding"common"regulatory"variants"that"have"been"fineAmapped"at"450" near"single"base"pair"resolution4."451" In" conclusion," we" hereby" provide" to" the" scientific" community" a" collection" of"452"




Sample$collection$in$the$CEDAR$cohort"469" We" collected" peripheral" blood" as"well" as" intestinal" biopsies" (ileum," transverse"470" colon,"rectum)"from"323"healthy"Europeans"visiting"the"Academic"Hospital"of"the"471" University" of" Liège" as" part" of" a" national" screening" campaign" for" colon" cancer.""472" Participants" included" 182" women" and" 141" men," averaging" 56" years" of" age"473" (range:" 19A86)." " " Enrolled" individuals" were" not" suffering" any" autoimmune" or"474" inflammatory" disease" and"were" not" taking" corticosteroids" or" nonAsteroid" antiA475" inflammatory" drugs" (with" the" exception" of" low" doses" of" aspirin" to" prevent"476" thrombosis)." "We"recorded"birth"date,"weight,"height,"smoking"history,"declared"477" ethnicity" and" hematological" parameters" (red" blood" cell" count," platelet" count,"478" differential" white" blood" cell" count)" for" each" individual." " The" experimental"479" protocol" was" approved" by" the" ethics" committee" of" the" University" of" Liège"480" Academic" Hospital." " Informed" consent" was" obtained" prior" to" donation" in"481" agreement" with" the" recommendations" of" the" declaration" of" Helsinki" for"482" experiments" involving"human"subjects." " " "We"refer" to" this"cohort"as"CEDAR" for"483" Correlated"Expression"and"Disease"Association"Research."""""""484"
SNP$genotyping$and$imputation$485" Total" DNA" was" extracted" from" EDTAAcollected" peripheral" blood" using" the"486" MagAttract" DNA" blood" Midi" M48" Kit" on" a" QIAcube" robot" (Qiagen)." " DNA"487" concentrations"were"measured"using" the"QuantAiT" Picogreen"ds"DNA"Reagents"488" (Invitrogen)." " " Individuals" were" genotyped" for" >" 700K" SNPs" using" Illumina’s"489" Human" OmniExpress" BeadChips," an" iScan" system" and" the" Genome" Studio"490" software"following"the"guidelines"of"the"manufacturer." " "We"eliminated"variants"491" with"call"rate"≤"0.95,"deviating" from"HardyAWeinberg"equilibrium"(p"≤"10A4),"or"492" which"were"monomorphic." "We"confirmed"European"ancestry"of"all" individuals"493" by"PCA"using"the"HapMap"population"as"reference." "Using"the"real"genotypes"of"494" 629,570" qualityAcontrolled" autosomal" SNPs" as" anchors," we" used" the" Sanger"495" Imputation" Services" with" the" UK10K" +" 1,000" Genomes" Phase" 3" Haplotype"496" panels43A46"to" impute" genotypes" at" autosomal" variants" in" our" population." " "We"497"
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eliminated" indels," SNPs" with" MAF" ≤" 0.05," deviating" from" HardyAWeinberg"498" equilibrium" (p" ≤" 10A3)," and" with" low" imputation" quality" (INFO" ≤" 0.4)," leaving"499" 6,019,462"high"quality"SNPs"for"eQTL"analysis."""""""""""""500"
Transcriptome$analysis$501" Blood"samples"were"kept"on"ice"and"treated"within"one"hour"after"collection"as"502" follows." " EDTAAcollected" blood" was" layered" on" FicollAPaque" PLUS" (GE"503" Healthcare)" to" isolate" peripheral" blood"mononuclear" cells" by" density" gradient"504" centrifugation.""CD4+"T"lymphocytes,"CD8+"T"lymphocytes,"CD19+"B"lymphocytes,"505" CD14+"monocytes,"CD15+"granulocytes"were"isolated"by"positive"selection"using"506" the"MACS"technology"(Miltenyi"Biotec)." " "To"isolate"platelets,"blood"collected"on"507" acidAcitrateAdextrose" (ACD)" anticoagulant" was" centrifuged" at" 150g" for" 10"508" minutes." " The" platelet" rich" plasma" (PRP)" was" collected," diluted" 2Afold" in" ACD"509" buffer" and" centrifuged" at" 800g" for" 10" minutes." " The" platelet" pellet" was"510" resuspended"in"MACS"buffer"(Miltenyi"Biotec)"and"platelets"purified"by"negative"511" selection" using" CD45" microbeads" (Miltenyi" Biotec)." " " Intestinal" biopsies" were"512" flash" frozen" in" liquid" nitrogen" immediately" after" collection" and" kept" at" A80°C"513" until" RNA" extraction." Total" RNA" was" extracted" from" the" purified" leucocyte"514" populations" and" intestinal" biopsies" using" the" AllPrep"Micro" Kit" and" a" QIAcube"515" robot"(Qiagen).""For"platelets,"total"RNA"was"extracted"manually"with"the"RNeasy"516" Mini"Kit"(Qiagen)." "Whole"genome"expression"data"were"generated"using"HTA12"517" Expression"Beadchips"following"the"instructions"of"the"manufacturer"(Illumina).""518" Technical"outliers"were"removed"using"controls" recommended"by" Illumina"and"519" the"Lumi"package47." "We"kept"29,464/47,323"autosomal"probes"(corresponding"520" to" 19,731" genes)" mapped" by" ReAAnnotator48" to" a" single" gene" body" with" ≤" 2"521" mismatches" and" not" spanning" known" variants" with" MAF" >" 0.05." " Within" cell"522" types,"we"only"considered"probes"(i.e."“usable”"probes)"with"detection"pAvalue"≤"523" 0.05"in"≥"25%"of"the"samples." " "Fluorescence"intensities"were"Log2"transformed"524" and"Robust"Spline"Normalized"(RSN)"with"Lumi47." "Normalized"expression"data"525" were"corrected"for"sex,"age,"smoking"status"and"Sentrix"Id"using"ComBat"from"the"526" SVA"R"library49."""We"further"corrected"the"ensuing"residuals"within"tissue"for"the"527" number"of" Principal" Components" (PC)" that"maximized" the"number"of" cisAeQTL"528" with" p" ≤" 10A6" 50." " Supplementary" Table" 2" summarizes" the" number" of" usable"529" samples,"probes"and"PC"for"each"tissue"type."530"
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CisIeQTL$analysis$531" CisAeQTL"analyses"were"conducted"with"PLINK"and"using" the"expression" levels"532" precorrected" for" fixed" effects" and" PC" as" described" above51,52." " Analyses" were"533" conducted" under" an" additive"model," i.e." assuming" that" the" average" expression"534" level" of" heterozygotes" is" at" the"midpoint" between" alternate" homozygotes." " To"535" identify"cisAeQTL"we"tested"all"SNPs"in"a"2Mb"window"centered"around"the"probe"536" (if" “usable”)." " " PAvalues" for" individual" SNPs" were" corrected" for" the" multiple"537" testing" within" the" window" by" permutation" (10,000" permutations)." " " For" each"538" probeAtissue" combination"we" kept" the" best" (corrected)" pAvalue." " " "Within" each"539" individual"cell" type," the"ensuing" list"of"corrected"pAvalues"was"used"to"compute"540" the"corresponding"false"discovery"rates"(FDR"or"qAvalue).""Supplementary"Table"541" 3" reports" the" number" of" cisAeQTL" found" in" the" nine" analyzed" cell" types" for"542" different"FDR"thresholds"(see"also"Supplementary"Figure"9).""""""""543"
Comparing$EAP$with$ϑ"to"identify$cis$Regulatory$Modules$544" If" the" transcript" levels" of" a" given" gene" are" influenced" by" the" same" regulatory"545" variants" (one" or" several)" in" two" tissues," the" corresponding" EQTL" Association"546" Patterns"(EAP)(i.e."the"Alog(p)"values"of"association"for"the"SNPs"surrounding"the"547" gene)"are"expected" to"be"similar." " "Likewise," if" the" transcript" levels"of"different"548" genes"are"influenced"by"the"same"regulatory"variants"in"the"same"or"in"different"549" tissues,"the"corresponding"EAP"are"expected"to"be"similar"(cfr."main"text,"Fig."1)."""550" We"devised"a"metric,"!," to"quantify"the"similarity"between"EAP." " If" two"EAP"are"551" similar," one" can" expect" the" corresponding" –log(p)" values" to" be" positively"552" correlated."""One"particularly"wants"the"EAP"peaks,"i.e."the"highest"Alog(p)"values,"553" to"coincide"in"order"to"be"convinced"that"the"corresponding"cisAeQTL"are"driven"554" by"the"same"regulatory"variants."""To"quantify"the"similarity"between"EAP"while"555" emphasizing" the" peaks" we" developed" a" weighted" correlation." " " Imagine" two"556" vectors"X"and"Y"of"–log(p)"values"for"n"SNPs"surrounding"the"gene(s)"of"interest."""557" Using" the" same" nomenclature" as" in" Fig." 1A," X" could" correspond" to" gene" A" in"558" tissue"1,"and"Y"to"gene"A"in"tissue"2,"or"X"could"correspond"to"gene"A"in"tissue"1,"559" and"Y" to"gene"B"in"tissue"2." "We"only"consider"for"analysis,"SNPs"within"1Mb"of"560" either" gene" (probe)" and" for"which"!! "and/or"!! "is" superior" to"1.3" (i.e." pAvalue"<"561" 0.05)" hence" informative" for" at" least" one" of" the" two" cisAeQTL." " " Indeed," the"562"
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majority"of"variants"with"–log(p)"<"1.3"(p">"0.05)"for"both"EAP"are"by"definition"563" not"associated"with"either"trait.""There"is"therefore"no"reason"to"expect"that"they"564" could" contribute" useful" information" to" the" correlation"metric:" their" ranking" in"565" terms" of" –log(p)" values" becomes" more" and" more" random" as" the" –log(p)"566" decreases."""We"define"the"weight"to"be"given"to"each"SNP"in"the"correlation"as:"567"
!! = !"# !!!!"# , !!!!"# !"The"larger"p,"the"more"weight"is"given"to"the"top"SNPs.""In"this"work,"p"was"set"at"568" one."569" The"weighted"correlation"between"the"two"EAP,"rw,"is"then"computed"as:"570"
!! = 1 !!!!!! !!!!!! !! − !!!!! !! − !!!!! "in"which"571"
!! = !! !×!!!!!!! !!!!!! "
!! = !! !×!!!!!!! !!!!!! "
!!! = !! !×! !! − !! !!!!! !!!!!! "
!!! = !! !×! !! − !! !!!!! !!!!!! ""572" The" larger" rw," the" larger" the" similarity" between" the" EAP," particularly" for" their"573" respective"peak"SNPs."574"
rw"ignores"an"important"source"of"information.""If"two"EAP"are"driven"by"the"same"575" regulatory"variant,"there"should"be"consistency"in"the"signs"of"the"effects"across"576" SNPs"in"the"region.""We"will"refer"to"the"effect"of"the"“reference”"allele"of"SNP"i"on"577" the" expression" levels" for" the" first" and" second" cisAeQTL" as"!!!"and"!!! ." " If" the"578"
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reference"allele"of"the"regulatory"variant"increases"expression"for"both"cisAeQTL,"579" the!!!!"and"!!!‘s"for"a"SNPs"in"LD"with"the"regulatory"variant"are"expected"to"have"580" the"same"sign"(positive"or"negative"depending"on"the"sign"of"D"for"the"considered"581" SNP)." " " If" the"reference"allele"of" the"regulatory"variant" increases"expression" for"582" one"cisAeQTL"and"decreases"expression"for"the"other,"the!!!!"and"!!!‘s"for"a"SNPs"583" in"LD"with"the"regulatory"variant"are"expected"to"have"opposite"sign." " "We"used"584" this"notion" to"develop"a"weighted"and"signed"measure"of" correlation,"rws." " "The"585" approach"was"the"same"as"for"rw,"except"that"the"values"of"!! "were"multiplied"by"A586" 1" if" the" signs" of"!!!"and"!!!"were" opposite." " " rws"is" expected" to" be" positive" if" the"587" regulatory"variant"affects"the"expression"of"both"cisAeQTL"in"the"same"direction"588" and"negative"otherwise.""589" We"finally"combined"rw"and"rws"in"a"single"score"referred"to"as"!, as!follows:""590"
! = !!"1+ !!!(!!!!)""ϑ"penalizes"rws"as"a"function"of"the"value"of"rw."""The"aim"is"to"avoid"considering"591" EAP"pairs"with"strong"but"negative"rw"(which"is"often"the"case"when"the"two"EAP"592" are" driven" by" very" distinct" variants)." " The" link" function" is" a" sigmoidAshaped"593" logistic" function"with"k"as"steepness"parameter"and"T"as"sigmoid"midApoint." " In"594" this"work,"we" used" a" value" of"k'of" 30," and" a" value" of"T" of" 0.3" (Supplementary"595" Figure"10).""""""""596" We" first" evaluated" the" distribution" of"!"for" pairs" of" EAP" driven" by" the" same"597" regulatory" variants" by" studying" 4,693" significant" cisAeQTL" (FDR" <" 0.05)." " For"598" these," we" repeatedly" (100" x)" split" our" CEDAR" population" in" two" halves,"599" performed"the"cisAeQTL"analysis"separately"on"both"halves"and"computed"ϑ" for"600" the"ensuing"EAP"pairs."Supplementary"Figure"1"is"showing"the"obtained"results.'""'""601" We" then" evaluated" the" distribution" of"!"for" pairs" of" EAP" driven" by" distinct"602" regulatory"variants"in"the"same"chromosomal"region"as"follows."""We"considered"603" 1,207" significant" cisAeQTL" (mapping" to" the"200" IBD" risk" loci" described" above)."604" For"each"one"of"these,"we"generated"a"set"of"100"“matching”"cisAeQTL"effects" in"605" silico," sequentially" considering" 100" randomly" selected" SNPs" (from" the" same"606" locus)" as" causal." " The" in" silico" cisAeQTL" were" designed" such" that" they" would"607" explain" the"same" fraction"of"expression"variance"as" the"corresponding" real" cisA608"
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eQTL" detected" with" PLINK" (cfr." above)." " " When" performing" cisAeQTL" analysis"609" under"an"additive"model,"PLINK"estimates"!!!"(i.e."the"intercept),"and"!!"(i.e."the"610" slope"of"the"regression),"including"for"the"top"SNP." "Assume"that"the"expression"611" level" of" the" studied" gene," Z," for" individual" i" is" zi' .' Assume" that" the" sample"612" comprises" nT' individuals" in" total," of" which" n11" are" of" genotype" “11”," n12" of"613" genotype" “12”," and" n22" of" genotype" “22”," for" the" top" cisAeQTL" SNP." " The" total"614" expression"variance"for"gene"Z"equals:"615"
!!! = !! − !! !!!!!!!! − 1 "The"variance"in"expression"level"due"to"the"cisAeQTL"equals:"616"
!!"#$! = !!! !! − !! ! + !!" !! + !! − !! ! + !!! !! + 2!! − !! !!! "The" heritability" of" expression" due" to" the" cisAeQTL," i.e." the" fraction" of" the"617" expression"variance"that"is"due"to"the"cisAeQTL"is"therefore:"618"
ℎ!"#$! = !!"#$!!!! "To" simulate" cisAeQTL"explaining" the" same"ℎ!"#$! "as" the" real" eQTL" in" the"CEDAR"619" dataset,"we" sequentially" considered" all" SNPs" in" the" region." " " Each"one"of" these"620" SNPs"would"be"characterized"by"n11"individuals"of"genotype"“11”,"n12"of"genotype"621" “12”,"and"n22"of"genotype"“22”,"for"a"total"of"nT'genotyped"individuals.""We"would"622" arbitrarily" set"!!!,"!!", and!!!!"at" A1," 0" and"+1." " " As" a" consequence," the" variance"623" due"to"this"cisAeQTL"equals:"624"
!!"#$! = !!! −1− !! ! + !!" 0− !! ! + !!! 1− !! !!! "in"which"!! = !!! − !!! !! ."625" Knowing"!!"#$! "and"ℎ!"#$! ,"and"knowing"that""626"
ℎ!"#$! = !!"#$!!!"#$! + !!"#! "the"residual"variance"!!"#! "can"be"computed"as"627"
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!!"#! = !!"#$! 1ℎ!"#$! − 1 "Individual"expression"data"for"the"corresponding"cisAeQTL"(for"all"individuals"of"628" the"CEDAR"dataset)"were"hence"sampled"from"the"normal"distribution"629" !!~! !!! ,!!"#! "where"!!!""is"A1,"0"or"+1"depending"on"the"genotype"of"the"individual"(11,"12,"or"630"
22)." " We" then" performed" cisAeQTL" on" the" corresponding" data" set" using" EAP,"631" generating"an"in"silico"EAP."""Real"and"in"silico"EAP"were"then"compared"using"ϑ."632" Supplementary" Figure" 1" shows" the" corresponding" distribution" of" ϑ" values" for"633" EAP"driven"by"distinct"regulatory"variants."634" The"corresponding"distributions"of"ϑ"under"H1"and"H0"(Supplementary"Figure"1)"635" show"that"ϑ"discriminates"very"effectively"between"H1"and"H0"especially"for"the"636" most"significant"cisAeQTL.""In"the"experiment"described"above,"this"would"yield"a"637" false"positive"rate"of"0.05,"and"a"false"negative"rate"of"0.23.""We"chose"a"threshold"638" of" ! >!0.6" to" cluster" EAP" in" cisAacting" regulatory" elements" or" cRM" (Fig." 2)."""639" Clusters"were"visually" examined"as" show" in" Supplementary"Figure"2." "TwentyA640" nine"edges"connecting"otherwise"unlinked"and"yet"tight"clusters"were"manually"641" removed.""642"
Testing$for$an$excess$sharing$of$cRM$between$cell$types$643" Assume" that" cell" type" 1" is" part" of" "!!! "cRM," including"!!!"private" cRM,"!!""cRM"644" shared"with"cell"type"2,"!!""cRM"shared"with"cell"type"2,"…,"and"!!""cRM"shared"645" with" cell" type"9."Note" that" !!!!!!! ≥ !!! ," because" cRM"may" include"more" than"646" two"cell"types.""Assume"that"!!! = !!!!!!! "is"the"sum"of"pairAwise"sharing"events"647" for"cell"type"1.""We"computed,"for"each"cell"type"! ≠ 1,"the"probability"to"observe"648" ≥ !!! ""sharing"events"with"cell"type"1"assuming"that"the"expected"number"(under"649" the"hypothesis"of"random"assortment)"is""650"
!!!× !!"!!"!!!! "PairAwise" sharing" events" between" tissue" 1" and" the" eight" other" tissues" were"651" generated"in"silico"under"this"model"of"random"assortment"(5,000"simulations)."652"
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The" pAvalue" for"!!! "was" computed" as" the" proportion" of" simulations" that"would"653" yield"values"that"would"be"as"large"or"larger"than"!!! ." " "The"same"approach"was"654" used" for" the"nine"cell" types."Thus," two"pAvalues"of"enrichment"are"obtained" for"655" each" pair" of" cell" types"!"and"!," one" using"!"as" reference" cell" type," and" the" other"656" using"!"as"reference"cell"type.""As"can"be"seen"from"Fig."5,"the"corresponding"pairs"657" of"pAvalues"were"always"perfectly"consistent.""658" We"performed"eight" distinct" analyses." In" the" first" analysis,"we"only" considered"659" cRM" involving" no" more" than" two" tissues" (i.e." unique" for" specific" pairs" of" cell"660" types)." " In" subsequent" analyses,"we" progressively" included" cRM"with" no"more"661" than"three,"four,"…,"and"nine"cell"types."662"
Comparing$EAP$and$DAP$using$ϑ"663" The" approach" used" to" cluster" EAP" in" cRM" was" also" used" to" assign" Disease"664" Association" Patterns" (DAP)" for" Inflammatory" Bowel" Disease" (IBD)" to" EAPA"665" defined" cRM." " "We" studied" 200" IBD" risk" loci" identified" in" recent" GWAS"metaA666" analyses2,3." " The" limits" of" the" corresponding" risk" loci" were" as" defined" in" the"667" corresponding"publications." " " " " "We"measured" the" similarity" between"DAP" and"668" EAP"using"the"ϑ"metric" for"all"cisAeQTL"mapping"to"the"corresponding"intervals"669" (i.e." for" all" cisAeQTL" for" which" the" top" SNP"mapped" within" the" interval)." " " To"670" compute"the"correlations"between"DAP"and"EAP"we"used"all"SNPs"mapping"to"the"671" disease"interval"with"–log(p)"value"≥"1.3"either"for"DAP,"EAP"or"both."672" In"addition"to"computing"ϑ'as"described"in"section"5,"we"computed"an"empirical"673" pAvalue" for" ϑ' using" the" approach" (based" on" in" silico" generated" cisAeQTL)"674" described" above" to" generate" the" locusAspecific" distribution" of"ϑ'values" for"EAP"675" driven" by" distinct" regulatory" variants." " From" this" distribution," one" can" deduce"676" the"probability"that"a"randomly"generated"EAP"(explaining"as"much"variance"as"677" the"real"tested"EAP)"and"the"DAP"would"by"chance"have"a" ! 'value"that"is"as"high"678" or"higher"than"the"real"EAP." "The"corresponding"empirical"pAvalue"accounts" for"679" the"local"LD"structure"between"SNPs."680"
Evaluating$the$enrichment$of$DAPIEAP$matching$$681" To" evaluate" whether" DAP" matched" EAP" more" often" than" expected" by" chance"682" alone,"we"analyzed"97"IBD"risk"loci"interrogated"by"the"Immunochip,"(i)"in"order"683"
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to" allow" for" convenient" comparison" with" Huang" et" al.4," and" (ii)" because" we"684" needed"extensively"QC"genotypes"for"the"IIBDGC"data"to"perform"the"enrichment"685" analysis"with"the"!Abased"method"(see"hereafter)."""Within"these"97"IBD"risk"loci,"686" we" focused" on" 63" regions" affecting" CD4," encompassing" at" least" one" significant"687" eQTL,"and"for"which"the"lead"CDAassociated"SNP"had"MAF">"0.05.""Indeed,"eQTL"688" analyses" in" the" CEDAR" dataset" were" restricted" to" SNPs"with"MAF" >" 0.05" (see"689" above)." "We" used" three"methods" to" evaluate"whether" the" observed" number" of"690" DAPAEAP"matches"were"higher"than"expected"by"chance"alone:"naïve,"frequentist"691" and"!Abased."""Analyses"were"performed"separately"for"the"nine"cell"types."""""$692" In" the" “naïve”" approach," DAP" and" EAP" were" assumed" to" match" if" the"693" corresponding" lead" SNPs"were" in" LD"with"!! ≥ 0.8." " This"would" yield"!! ≤ 63"694" risk" loci" for" which" the" DAP" would" match" at" least" one" EAP." " " To" measure" the"695" statistical"significance"of"!! ,"we"sampled"a"SNP"(MAF">"0.05)"at"random"in"each"696" of"the"63"risk"loci,"and"counted"the"number"of"loci"with"at"least"one"matching"EAP.""697" This" “simulation”" was" repeated" 1,000" times." " The" significance" of"!! "was"698" measured"as"the"proportion"of"simulations"that"would"yield"≥ !!"matches."699" The" frequentist"approach"used"the"method"described"by"Nica"et"al.53." "DAP"and"700" EAP" were" assumed" to" match" if" fitting" the" diseaseAassociated" lead" SNP" in" the"701" eQTL"analysis"caused"a"larger"drop"in"– log!(!)"than"95%"of"the"SNPs"with"MAF">"702" 0.05"in"the"analyzed"risk"locus.""This"would"yield"!! ≤ 63"risk"loci"for"which"the"703" DAP"would"match"at"least"one"EAP."""To"measure"the"statistical"significance"of"!! ,"704" we" sampled" a" SNP" (MAF" >" 0.05)" at" random" in" each" of" the" 63" risk" loci," and"705" counted" the"number"of" loci"with" at" least" one"matching"EAP." " This" “simulation”"706" was" repeated" 1,000" times." " The" significance" of"!! "was" measured" as" the"707" proportion"of"simulations"that"would"yield"≥ !! "matches."708" Finally,"we"used"our"!Abased"approach"in"which"DAP"and"EAP"were"assumed"to"709" match" if" ! > 0.6." This"would" yield"!! ≤ 63"risk" loci" for"which" the"DAP"would"710" match"at"least"one"EAP."""To"measure"the"statistical"significance"of"!!"we"sampled"711" a"SNP"(MAF">"0.05)"at"random"in"each"of"the"63"risk"loci,"and"generated"a"DAP"712" assuming"that"the"corresponding"SNPs"were"causal"as"follows.""713"
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Assume"a"cohort"with"!!"cases"and"!!!controls"(f.i."the"IIBDGC"cohort).""Assume"a"714" SNP"with"an"allelic"frequency"of"!"in"the"cases"+"controls,"an"allelic"frequency"of"715" ! + ! "in"cases"and" ! + ! "in"controls."716" One"can"easily"show"that:"717" ! = −! !!!!"""""(1)"718" The"odds"ratio"(OR)"for"that"SNP"equals:"719"
!" = (! + !)(1− ! − !)(! + !)(1− ! − !)"The"ratio"between"the"betweenAcohort" (i.e." cases"and"controls)"variance"versus"720" withinAcohort"variance"(corresponding"to"an"F"test)"can"be"shown"to"equal:"721"
! = !! 1+ !!!!1+ !!!! ! − !! − !! 1+ !!!! "If" we" fix" F" based" on" the" real" top" SNP" in" the" IIBDGC" data" in" a" given" GWAS"722" identified" risk" loci,"we" can" determine"!"(and" hence"!"using" equation" 1)" for" the"723" randomly" selected" SNP" (that"will" become" an" “in" silico" causative" variant”)"with"724" allelic" frequency" in" (cases"+"controls)"of"!"(different" from"the"real" top"SNP),"by"725" solving""726"
! = −! ± !! − 4!"2! ""where""727"
! = (1+ !!!!)(1+ !)"! = 0"
! = − ! − !! 1+ !!!! !"Once"we"know"(! + !)"(i.e."the"frequency"of"the"SNP"in"cases),"and"hence"(! + !)"728" (i.e." the" frequency" of" the" SNP" in" controls)," we" can" use" Hardy–Weinberg" to"729" determine" the" frequency" of" the" three" genotypes" in" cases" (!!!!"# ,!!"!"# ,!!!!"#)" and"730"
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controls" (!!!!"# ,!!"!"# ,!!!!"#)." "We" then" create" an" in" silico" caseAcontrol" cohort" by"731" sampling" (with" replacement)" !!×!!!!"# "AA" cases," !!×!!"!"# AB" cases," …," and"732" !!×!!!!"# "BB"controls"from"the"individuals"of"the"IIBDGC"(without"discriminating"733" real"case"and"control"status)." "Association"analysis"of"the"corresponding"dataset"734" in" the" chromosome" region" of" interest" generates" DAP" with" max"– log ! "value"735" similar" to" the" real" DAP." This" “simulation”" was" repeated" 1,000" times." " The"736" significance" of"!!"was" measured" as" the" proportion" of" simulations" that" would"737" yield"≥ !!"matches.""738"
Targeted$exon$resequencing$in$CD$cases$and$controls$739"
$Genes" for" which" EAP" match" the" DAP" tightly" (high" ! 'values)" are" strong"740" candidate"causal"genes"for"the"studied"disease.""In"the"case"of"IBD,"we"identified"741" ~100" such" genes" (Table" 1)." " " Ultimate" proof" of" causality" can" be" obtained" by"742" demonstrating" a" differential" burden" of" rare" disruptive" variants" in" cases" and"743" controls." " Burden" tests" preferably" focus" on" coding" gene" segments," in" which"744" disruptive" variants" are" most" effectively" recognized." Analyses" are" restricted" to"745" rare"variants"to"ensure"independence"from"the"GWAS"signals."""746" To"perform"burden" tests,"we"collected"DNA"samples" from"7,323"Crohn"Disease"747" (CD)" cases" and" 6,342" controls" of" European" descent" in" France" (cases:" 1,899" –"748" ctrls:"1,731),"the"Netherlands"(2,002"–"1,923)"and"Belgium"(3,422"–"2,688).""The"749" study"protocols"were"approved"by"the"institutional"review"board"at"each"centre"750" involved"with"recruitment." " Informed"consent"and"permission"to"share"the"data"751" were"obtained" from"all"subjects," in"compliance"with" the"guidelines"specified"by"752" the"recruiting"centre’s"institutional"review"board.""753" During" the"course"of" this"project,"we"selected"45"genes"with"high" ! 'values" for"754" resequencing" (Table" 1)." " We" designed" primers" to" amplify" all" corresponding"755" coding" exons" plus" exonAintron" boundaries" corresponding" to" all" transcripts"756" reported"in"the"CCDS"release"1554"(Supplemental"data"8).""Following"Momozawa"757" et" al.55," the"primers"were"merged" in" five"pools" to"perform"a" first" round"of"PCR"758" amplification"(25"cycles)." "We"then"added"8Abp"barcodes"and"common"adaptors"759" (for" sequencing)" to" all" PCR" products" by" performing" a" second" round" of" PCR"760" amplification"(4"cycles)"using"primers" targeting"shared"5’overhangs" introduced"761" during"the"first"PCR.""The"ensuing"libraries"were"purified,"quality"controlled"and"762"
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sequenced"(2"x"150Abp"pairedAend"reads)"on"a"HiSeq"2500"(Illumina)"instrument.""763" Sequence" reads" were" sorted" by" individual" using" the" barcodes," aligned" to" the"764" human" reference" sequence" (hg19)" with" the" BurrowsAWheeler" Aligner" (ver."765" 0.7.12)56,"and"further"processed"using"Genome"Analysis"Toolkit"(GATK,"ver."3.2A766" 2)57." "We"only"considered"individuals"for"further"analyses"if"≥"95%"of"the"target"767" regions" was" covered" ≥" 20" sequence" reads." " Average" sequence" depth" across"768" individuals"and"target"regions"was"1,060."We"called"variants"for"each"individual"769" separately"using"the"UniﬁedGenotyper"and"HaplotypeCaller"of"GATK,"as"well"as"770" VCMM"(ver."1.0.2)58,"and"listed"all"variants"detected"by"either"method."Genotypes"771" for" all" individuals" were" determined" for" each" variant" based" on" the" ratio" of"772" reference" and" alternative" alleles" amongst" sequence" reads" as" determined" by"773" Samtools59." " Individuals" were" labelled" homozygote" reference," heterozygote," or"774" homozygote" derived"when" the" alternative" allele" frequency"was" between"0" and"775" 0.15," between" 0.25" and" 0.75," and" between" 0.85" and" 1," respectively." If" the"776" alternative"allele" frequency"was"outside" these"ranges"or"a"variant"position"was"777" covered"with"<"20"sequencing"reads,"the"genotype"was"considered"missing.""We"778" excluded" variants" with" call" rates" <" 95%" or" variants" that" were" not" in" HardyA779" Weinberg"equilibrium"(P"<"1"x"10A6)."We"excluded"281"individuals"with"≥"2"minor"780" alleles" at" 23" variants" selected" to" have" a"MAF"≤"0.01" in" nonAFinnish"Europeans"781" and"≥"0.10"in"Africans"or"EastAAsians"in"the"Exome"Aggregation"Consortium60.""782" In" the" end,"we"used"6,597" cases" and"5,502" controls" for" further" analyses,"while"783" 98.5%"of"the"target"regions"on"average"was"covered"with"20"or"more"sequence"784" reads."785"
GeneIbased$burden$test$786" We" first" used" SIFT61" and" PolyphenA262" to" sort" the" 4,175" variants" identified" by"787" sequencing"in"four"categories:"(i)"lossAofAfunction"(LoF)"or"severe,"corresponding"788" to" stop" gain," stop" loss," frameshift" and" spliceAsite" variants," (ii)" damaging,"789" corresponding" to" missense" variants" predicted" by" SIFT" to" be" damaging" and"790" PolyphenA2"to"be"possibly"or"probably"damaging," (iii)"benign,"corresponding"to"791" the" other" missense" variants," and" (iv)" synonymous." We" performed" the" burden"792" test"using"the"LoF"plus"damaging"variants,"and"used"the"synonymous"variants"as"793" controls." " We" only" considered" variants" with" MAF" (computed" for" the" entire"794"
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dataset," i.e."cases"plus"controls)"≤"0.005." "We"indeed"showed"in"a"previous"fineA795" mapping" study" that" all" reported" independent" effects" were" driven" by" variants"796" with"MAF"≥"0.014.""By"doing"so"we"ensure"that"the"signals"of"the"burden"test"are"797" independent" of" previously" reported" association" signals." " " Thus," 174" LoF," 991"798" damaging,"and"1,434"synonymous"were"ultimately"used"to"perform"burden"tests."""$799" Burden"tests"come"in"two"main"flavors."""In"the"first,"one"assumes"that"disruptive"800" variants"will"be"enriched"in"either"cases"(i.e."disruptive"variants"increase"risk)"or"801" in"controls" (i.e."disruptive"variance"decrease"risk)." " In" the"second,"one"assumes"802" that"A"for"a"given"gene"A"some"disruptive"variants"will"be"enriched"in"cases,"while"803" other" may" be" enriched" in" controls" (Supplementary" Fig." 11)." The" first" was"804" implemented" using" CAST63." " To" increase" power," we" exploited" the" DAPAEAP"805" information"to"perform"oneAsided"(rather"than"twoAsided)"tests."""When"ϑ"<"0,"we"806" tested" for" an" enrichment" of" disruptive" variants" in" cases;" when" ϑ" >" 0," for" an"807" enrichment" of" disruptive" variants" in" controls." " " PAvalues" were" computed" by"808" phenotype" permutation," i.e." shuffling" caseAcontrol" status." " "When" applying" this"809" test" on" a" geneAbyAgene" basis" using" synonymous" variants" (MAF" >" 0.005)," the"810" distribution"of"pAvalues"(QQAplot)"indicated"that"the"CAST"test"was"conservative"811" (!!" = 0.51)!(Supplementary" Fig." 12)." " The" second" kind" of" burden" test" was"812" implemented"with"SKAT64."It"is"noteworthy"that"SKAT"ignores"information"from"813" singletons"(Supplementary"Fig."11)."Just"as"for"CAST,"pAvalues"were"computed"by"814" phenotype" permutation," i.e." shuffling" caseAcontrol" status." " "When" applying" this"815" test" on" a" geneAbyAgene" basis" using" synonymous" variants" (MAF" <" 0.005)," the"816" distribution"of"pAvalues"(QQAplot)"indicated"that"the"SKAT"test"is"too"permissive"817" ( !!" = 1.73) "(Supplementary" Fig." 12)." " Consequently," geneAbased" pAvalues"818" obtained" with" SKAT" were" systematically" GC" corrected" using" this" value" of"!!" .""819" We"performed" the" two"kinds"of" analyses" for"each"gene," as"one"doesn’t" a"priori"820" know"what"hypothesis"will"match"the"reality"best"for"a"given"gene.""""821" We" also" extracted" information" from" the" distribution" of" pAvalues" (or" –log(p)"822" values)" across" the" 45" analyzed" genes." " Even" if" individual" genes" do" not" yield" –823" log(p)"values"that"exceed"the"significance"threshold"(accounting"for"the"number"824" of" analyzed"genes"and" tests"performed)," the"distribution"of" –log(p)"values"may"825" significantly"depart"from"expectations,"indicating"that"the"analyzed"genes"include"826" at"least"some"causative"genes."""This"was"done"by"taking"for"each"gene,"the"best"pA827"
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value" (whether" obtained" with" CAST" or" SKAT)" and" then" rank" the" genes" by"828" corresponding" –log(p)" value." " " The" same" was" done" for" 105" phenotype"829" permutations,"allowing"us"to"examine"the"distribution"of"–log(p)"values"for"given"830" ranks"and"compute"the"corresponding"medians"and"limits"of"the"95%"confidence"831" band,"as"well"as"to"compute"the"probability"that"– 2 ln!(!!)!"!!! "(Fisher’s"equation"832" to"combine"pAvalues)"equals"or"exceeds" the"observed." " " " "Our"results"show"that"833" there" is"a"significant"departure" from"expectation"when"analyzing" the"damaging"834" variants" (p"="6.9"x"10A4)"but"not"when"analyzing" the"synonymous"variants" (p"="835" 0.66)"supporting"the"presence"of"genuine"causative"genes"amongst"the"analyzed"836" list."""837"
cRMIbased$burden$test$838" The"enrichment"of"multiAgenic" cRM" in" IBD" risk" loci" suggests" that" risk" loci"may"839" have"more"than"one"causative"gene"belonging"to"the"same"cRM."""To"capitalize"on"840" this"hypothesis,"we"developed"a"cRMAbased"burden"test." "GeneAspecific"pAvalues"841" were"combined"within"cRM"using"Fisher’s"method.""For"each"gene,"we"considered"842" the" best" pAvalue" whether" obtained" with" CAST" or" SKAT." Statistical" significance"843" was" evaluated" by" phenotype" permutation" exactly" as" described" for" the" geneA844" based"burden"test."""By"doing"so"we"observed"a"departure"from"expectation"when"845" using"the"damaging"variants"(p"="2.3"x"10A3),"but"not"when"using"the"synonymous"846" variants"(p"="0.72)."847"
Orthogonal$tests$for$ageIofIonset$and$familiality$848" It" is" commonly" assumed" that" the" heritability" for" common" complex" diseases" is"849" higher" in" familial" and" early" onset" cases65." " To" extract" the" corresponding"850" information" from"our" data" in" a"manner" that"would" be" orthogonal" to" the" geneA"851" and"moduleAbased"tests"described"above"(i.e."the"information"about"ageAofAonset"852" and" familiality" would" be" independent" of" these" burden" tests)," we" devised" the"853" following"approach.""854" For" ageAofAonset," we" summed" the" ageAofAonset" of" the" nC" cases" carrying" rare"855" disruptive"variants" for" the"gene"of" interest." "We" then"computed" the"probability"856" that" the" sum"of" the" ageAofAonset" of"nC" randomly" chosen" cases"was" as" different"857" from"the"mean"of"ageAofAonset"as"the"observed"one,"yielding"a"geneAspecific"twoA858"
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sided"pSKAT"value." In"addition,"we"used" the"eQTL" information" to"generate"geneA859" specific"oneAsided"pCAST"values,"corresponding"to"the"probability"that"the"sum"of"860" the" ageAofAonset" of" nC" randomly" chosen" cases" was" as" low" or" lower" than" the"861" observed" one" (for" genes" for" which" decrease" in" expression" level" as" associated"862" with"increased"risk),""or"to"the"probability"that"the"sum"of"the"ageAofAonset"of"nC"863" randomly"chosen"cases"was"as"high"or"higher"than"the"observed"one"(for"genes"864" for"which"increase"in"expression"level"as"associated"with"increased"risk)."These"865" ageAofAonset"pAvalues"were"then"combined"with"the"corresponding"pAvalues"from"866" the"burden"test"(CAST"with"CAST,"SKAT"with"SKAT)"using"Fisher’s"method."867" For" familiality," we" determined" what" fraction" of" the" nC" cases" carrying" rare"868" disruptive" variants" for" the" gene" of" interest"were" familial" (affected" first" degree"869" relative)."We" then" computed" the" probability" that" the" fraction" of" familial" cases"870" amongst"nC"randomly"chosen"cases"was"as"different"from"the"overall"proportion"871" of" familial" cases," yielding"a" geneAspecific" twoAsided"pSKAT" value." In"addition,"we"872" used" the" eQTL" information" to" generate" geneAspecific" oneAsided" pCAST" values,"873" corresponding" to" the" probability" that" the" fraction" of" familial" cases" amongst"nC"874" randomly"chosen"cases"was"as"high"or"higher"than"the"observed"one"(for"genes"875" for"which"decrease"in"expression"level"as"associated"with"increased"risk)," "or"to"876" the"probability" that" the" sum"of" the" ageAofAonset" of"nC" randomly" chosen"was" as"877" low"or"lower"than"the"observed"one"(for"genes"for"which"increase"in"expression"878" level" as" associated" with" increased" risk)." These" familial" pAvalues" were" then"879" combined" with" the" corresponding" pAvalues" from" the" burden" test" (CAST" with"880" CAST,"SKAT"with"SKAT)"using"Fisher’s"method.""881" "882"
DATA$AVAILABILITY$883" The"complete"CEDAR"eQTL"dataset"can"be"downloaded"from"the"Array"Express"884" website" (https://www.ebi.ac.uk/arrayexpress/)," accession" numbers" EAMTABA885" 6666"(genotypes)"and"EAMTABA6667"(expression"data).""The"data,"preprocessed"886" as" described" in" Methods," can" be" downloaded" from" the" CEDAR" website"887" (http://cedarAweb.giga.ulg.ac.be).""888" """""""""""""""889"
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Figure$Legends$1072"
Figure$1:$cis$Regulatory$Module$(cRM).$A"cisAeQTL"affecting"gene"A"in"tissue"1"1073" reveals"itself"by"an"“eQTL"Association"Pattern”"(EAPA,1),"i.e."the"pattern"of"–log(p)"1074" values" for" variants" in" the" region." " " Multiple" EAP" can" be" observed" in" a" given"1075" chromosome"region,"affecting"one"or"more"genes"in"one"or"more"cell"types."""EAP"1076" that"are"driven"by"the"same"underlying"variants"are"expected"to"be"similar,"while"1077" EAP"driven"by"distinct"variants"(f.i."the"green"and"red"regulatory"variants"in"the"1078" figure)"are"not.""Based"on"the"measure"of"similarity"introduced"in"this"work,"ϑ,"we"1079" cluster"the"EAP"in"cisARegulatory"Modules"(cRM).""For"EAP"in"the"same"module,"ϑ"1080" can" be" positive" or" negative," indicating" that" the" variants" have" the" same" sign" of"1081" effect"(increasing"or"decreasing"expression)"for"the"corresponding"EAP"pair."""1082"
Figure$2:$ SingleIgene/tissue$versus$multiIgene/tissue$cRM.$Using" ! > 0.6,"1083" the"23,950"cisAeQTL"(FDR"≤"0.05)"detected"in"the"nine"analyzed"cell"types"were"1084" clustered"in"9,691"cisARegulatory"Modules"(cRM).""68%"of"these"were"singleAgene,"1085" singleAtissue" cRM" (green)," 22%"were" singleAgene,"multiAtissue" cRM" (blue)," and"1086" 10%" were" multiAgene," mostly" multiAtissue" cRM" (red)." " The" number" of"1087" observations" for" singleAgene" cRM"were" divided" by" 10" in" the" graph" for" clarity."1088" Thus," there" are"more" cases" of" singleAgene,"multiAtissue" cRM" (blue;" 2,155)" than"1089" multiAgene"cRM"(red;"967)."""1090"
Figure$ 3:$ Example$ of$ a$ multiIgene,$ multiItissue$ cRM.$ " GeneAtissue"1091" combinations"for"which"no"expression"could"be"detected"are"marked"by"“A“,"with"1092" detectable"expression"but"without"evidence"for"cisAeQTL"as"“→”,"with"detectable"1093" expression"and"evidence"for"a"cisAeQTL"as"“↑”"or"“↓”"(large"arrows:"FDR"<"0.05;"1094" small" arrows:" FDR"≥"0.05" but" high" ! "values)." " eQTL" labelled" by" the" yellow"1095" arrows" constitute" the" multiAgenic" and" multiAtissular" cRM" n°57." The"1096" corresponding" regulatory" variant(s)" increase" expression" of" the"GINM1,"NUP43"1097" and"probably"KATNA1"genes"(left"side"of"the"cRM),"while"decreasing"expression"1098" of"the"PCMT1"and"LRP11"genes"(right"side"of"the"cRM)."The"expression"of"GINM1"1099" in"CD15"and"LRP11" in"CD4"appears" to"be" regulated" in"opposite"directions"by"a"1100" distinct"cRM"(n°3694,"green).""The"LATS1"gene,"in"the"same"region,"is"not"affected"1101" by" the" same" regulatory" variants" in" the" studied" tissues." Inset" 1:"!"values" for" all"1102"
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EAP"pairs."EAP"pairs"with" ! !> 0.6"are"bordered"in"yellow"when"corresponding"1103" to"cRM"n°57,"in"green"when"corresponding"to"cRM"n°3694"(+"green"arrow).""1104"
Figure$4:""Variant(s)$with$opposite$effects$on$expression$in$two$cell$ types."1105" Example"of"a"gene"(PNKD)"affected"by"a"cisAeQTL"in"at"least"two"cell"types"(CD14"1106" and"platelets)" that"are" characterized"by"EAP"with"ϑ"=" A0.97," indicating" that" the"1107" gene’s" expression" level" is" affected"by" the" same" regulatory"variant" in" these" two"1108" cell"types,"yet"with"opposite"effects,"i.e."the"variant"that"is"increasing"expression"1109" in"platelets"is"decreasing"expression"in"CD14.$$1110"
Figure$5:"Significance$of$the$excess$sharing$of$cRM$between$cell$types."(red:"1111" p"<"0.0002" (Bonferroni" corrected"0.0144),"orange:"p"<"0.001" (0.072)," rose:"p"<"1112" 0.01"(0.51)).""The"numbers"in"the"lowerAleft"corner"of"the"squares"indicate"which"1113" cRM"were"used"for"the"analysis:"(2)"cRM"affecting"no"more"than"two"cell" types,"1114" (3)" cRM" affecting" no" more" than" three" cell" types," etc." " The" upperAleft" square"1115" indicates" the" position" of" the" lymphoid" cell" types" (L)(CD4," CD8," CD19)," the"1116" myeloid"cell" types"(M)(CD14,CD15,PLA),"and" the" intestinal"cell" types"(I)(IL,"TR,"1117" RE)."For"each"pair"of"cell"types"!"and"!,"we"computed"two"pAvalues,"one"using"!!as"1118" reference," the" other" using"! "as" reference" (Methods)." Pairs" of" pAvalues" were"1119" always"consistent."1120"
Figure$6:$DAPImatching$cRM.$ $If"a"regulatory"variant"(red)"affects"disease"risk"1121" by"altering"the"expression"levels"of"gene"B"in"tissue"2,"the"EAPB,2"is"expected"to"be"1122" similar" (high" ! ) "to" the" “disease" association" pattern”" (DAP)," both" assigned"1123" therefore" to" the" same" cRM." " " ϑ" is" positive" if" increased" gene" expression" is"1124" associated"with" increased" disease" risk," negative" otherwise." " A" cisAeQTL" that" is"1125" driven"by"a"regulatory"variant"(green)"that"does"not"directly"affect"disease"risk,"1126" will"be"characterized"by"an"EAP"(say"gene"A,"tissue"2,"EAPA,2)"that"is"not"similar"to"1127" the"DAP"(low" ! ).$$1128"
Figure$7:$Screen$shots$of$the$CEDAR$website,"showing"(i)"known"CD"risk"loci"1129" on"the"human"karyotype,"(ii)"a"zoom"in"the"HD35"risk"locus"showing"the"Refseq"1130" gene"content"and"summarizing"local"CEDAR"cisAeQTL"data"(white:"no"expression"1131" data,"gray:"expression"data"but"no"evidence"for"cisAe,"black:"significant"cisAeQTL"1132" but" no" correlation" with" DAP," red:" significant" cisAeQTL" similar" to" DAP" (! ≤1133" −0.75),"green:"significant"cisAeQTL"similar"to"DAP"(! ≥ 0.75)),"and"(iii)"a"zoom"in"1134"
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the" DAP" for" Crohn’s" disease" (black)" and" EAP" for" IL18R1' (red)," as" well" as" the"1135" signed"correlation"between"DAP"and"EAP.""1136"
Figure$8:$Variants$detected$by$sequencing$the$coding$exons$of$45$candidate$1137"
genes." "Variants" are" sorted" in"LoF" (LossAofAFunction," i.e." stop"gain," frameAshift,"1138" splice" site),"Damaging"MS" (missense"variants" considered"as"damaging"by"SIFT5"1139" and"damaging"or"possibly"damaging"by"PolyphenA26),"Benign"MS"(other"missense"1140" variants),"and"Synonymous."Blue:"variants"with"MAF"<"0.005,"Red:"variants"with"1141" MAF"≥"0.005.""1142"
Figure$ 9:$ QQIplot$ for$ the$ geneIbased$ burden$ test." " Ranked" log(1/p)" values"1143" obtained" when" considering" LoF" and" damaging" variants" (full" circles)," or"1144" synonymous"variants"(empty"circles)." " "The"circles"are"labeled"in"blue"when"the"1145" best"pAvalue"for"that"gene"is"obtained"with"CAST,"in"red"when"the"best"pAvalue"is"1146" obtained"with" SKAT." The" black" line" corresponds" to" the"median" log(1/p)" value"1147" obtained" (for" the" corresponding" rank)" using" the" same" approach" on" permuted"1148" data" (LoF" and"damaging" variants)." " The" grey" line"marks" the"upper" limit" of" the"1149" 95%"confidence"band." "The"name"of" the"genes"with"nominal"pAvalue"≤ 0.05"are"1150" given." "Known"causative"genes"are"italicized." " "The"inset"pAvalue"corresponds"to"1151" the"significance"of"the"upwards"shift"in"log(1/p)"values"estimated"by"permutation."" "1152"
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Table$1$1153"
Loc$ Chr$ Beg$ End$ cRM$ Nr$ Genes$with$correlated$DAPIEAP$
Implicated$cell$
types$
Best$theta$ Best$p$ Ref$CD$ UC$ CD$ UC$HD1" 1" 2.4" 2.8" 271" 2" TNFRSF14' CD4"CD8"IL"TR" A0.74" A0.79" 0.02" 0.03" 4"36"HD2" 1" 7.7" 8.3" 2900" 1" PARK7" CD15"TR"RE" A0.8" A0.82" 0.01" 0.06" 36"N_1_62" 1" 62.5" 63.5" 109" 3" DOCK7$USP1"ATG4C" CD4"CD8"CD19"CD14"CD15" A0.9" 0" 0.01" 1.00" 3"N_1_100" 1" 101.0" 102.0" 6008" 1" SLC30A7" TR" 0" A0.71" 1.00" 0.06" "J_1_119" 1" 120.2" 120.7" 9459" 1" NOTCH2" CD19" 0.68" 0" 0.13" 1.00" "HD14" 1" 155.0" 156.1" 5" 8" GBA" CD4" A0.65" 0" 0.01" 1.00" "238" 3" THBS3'GBA"MUC1" CD14"CD15"TR" 0" 0.81" 1.00" 0.02" "4513" 1" THBS3' CD4" 0" 0.66" 1.00" 0.02" "HD21" 1" 197.3" 198.0" 6071" 1" DENND1B" CD4" 0.7" 0.78" 0.03" 0.02" ""HD30" 2" 62.4" 62.7" 3716" 1" B3GNT2" CD8" A0.63" 0" 0.01" 1.00" "HD35" 2" 102.8" 103.3" 1132" 1" IL18R1+ CD4$CD8$$ A0.93" A0.87" 0.01" 0.03" 4"8912" 1" (IL18RAP)" CD8" A0.42" 0" 0.11" 0.38" 4"J_2_197" 2" 198.2" 199.1" 325" 2" MARS2"PLCL1" CD4"CD14" A0.72" 0" 0.06" 1.00" 2"36"J_2_218" 2" 218.9" 219.4" 216" 3" PNKD"GPBAR1" CD14"TR"RE" 0.72" 0.72" 0.01" 0.06" 2"36"HD43" 2" 234.1" 234.6" 1177" 1" ATG16L1+ CD4"CD8"IL"TR"RE" 0.94" 0" 0.05" 1.00" 2"39"
N_3_45" 3" 46.0" 47.0" 2930" 1" CCR2" CD19" 0.77" 0" 0.02" 1.00" "1203" 1" CCR2" CD4" A0.62" 0" 0.07" 1.00" "7768" 1" CCR9" CD19" 0" A0.67" 1.00" 0.06" "6798" 1" KLHL18" CD14" 0" A0.68" 1.00" 0.03" "HD50" 3" 48.4" 51.4" 8" 7" USP4' CD19" 0.64" 0.63" 0.06" 0.07" 2"217" 3" GPX1+APEH'IP6K1' CD19"CD14"TR$RE" 0.91" 0.97" 0.01" 0.01" 2"39"122" 3" FAM212A' CD19" 0" 0.61" 1.00" 0.05" "J_3_52" 3" 52.8" 53.3" 3190" 1" SFMBT1" TR"RE" 0" A0.88" 1.00" 0.01" 37"J_4_73" 4" 74.6" 75.1" 1271" 1" CXCL5" CD4"CD8"CD19"CD14"PLA" 0" A0.84" 1.00" 0.01" 2"HD60" 5" 40.0" 40.7" " " (PTGER4)" CD15" 0" 0" 0.28" 0.15" 40"HD61" 5" 55.4" 55.5" 360" 2" ANKRD55$IL6ST$ CD4"CD8" 0.9" 0" 0.02" 1.00" 4"HD62" 5" 72.4" 72.6" 6625" 1" FOXD1" IL" A0.74" 0" 0.03" 1.00" 4"HD63" 5" 95.9" 96.5" 365" 2" ERAP2'LNPEP' CD4$CD8$CD19$CD14$CD15"PLA"IL$TR$RE" 0.94" 0.71" 0.01" 0.02" 2"4"37"HD65" 5" 130.4" 132.0" 55" 4" (SLC22A4)"(SLC22A5)" CD4"CD15" A0.55" 0" 0.06" 0.07" 4"41"HD66" 5" 141.4" 141.7" 2389" 1" NDFIP1' CD8"PLA" 0.87" 0.88" 0.04" 0.01" 2"HD67" 5" 149.0" 151.0" A" A" (IRGM)" A" A" A" A" A" 42"HD71" 5" 173.2" 173.6" 1349" 1" CPEB4' CD4"CD8"CD19"CD14$CD15"PLA"TR" A0.92" 0" 0.01" 1.00" 2"4"J_66_32" 6" 32.3" 32.9" 7853" 1" HLAADQA2" IL" 0" A0.62" 1.00" 0.02" "HD76" 6" 90.8" 91.1" 1404" 1" BACH2" CD4" 0.67" 0" 0.14" 1.00" "HD78" 6" 111.3" 112.0" 9603" 1" SLC16A10" IL" 0" A0.71" 1.00" 0.11" "HD80" 6" 127.9" 128.4" 707" 2" THEMIS"PTPRK" CD8$ A0.92" 0" 0.01" 1.00" "HD83" 6" 167.3" 167.6" 1425" 1" RNASET2' CD4"CD8"CD15"PLA" A0.87" 0" 0.02" 1.00" 4"J_7_1" 7" 2.5" 3.0" 2729" 1" GNA12$ CD19$CD14"TR$ 0" A0.94" 1.00" 0.02" 2"HD84" 7" 26.6" 27.3" 1441" 1" SKAP2+ CD4$CD8$CD19$ 0.97" 0" 0.01" 1.00" 4"HD85" 7" 28.1" 28.3" 6438" 1" JAZF1' CD4"" 0.78" 0" 0.01" 1.00" 2"HD92" 7" 128.5" 128.8" 401" 2" IRF5"TNPO3" CD15"IL" 0" A0.64" 1.00" 0.02" 2"36"7046" 1" TSPAN33" CD19" A0.64" 0" 0.01" 1.00" "N_8_26" 8" 26.7" 27.7" 5869" 1" PTK2B" CD14" A0.69" 0" 0.01" 1.00" "5841" 1" TRIM35" CD4" 0" 0.66" 1.00" 0.01" "HD106" 9" 139.1" 139.5" 64" 4" CARD9"INPP5E"SEC16A'SDCCAG3" CD4"CD8"CD19"CD14"CD15"IL"TR"RE" 0.95" 0.86" 0.01" 0.02" 2"4"37"HD109" 10" 30.6" 30.9" 1603" 1" MTPAP" TR" A0.62" 0" 0.11" 1.00" "HD112" 10" 59.8" 60.2" 1609" 1" CISD1+ CD4$CD8$CD19$CD14$CD15$TR"RE" 0.94" 0.83" 0.04" 0?01" 2"4"36"J_10_74" 10" 75.4" 75.9" 436" 2" VCL' CD4"CD8"CD19"CD14"RE" 0" A0.79" 1.00" 0.04" "4279" 1" CAM2KG" CD4" A0.67" 0" 0.04" 1.00" "HD114" 10" 81.0" 81.2" 5476" 1" ZMIZ1$ CD8$ A0.91" A0.86" 0.03" 0.01" "J_10_80" 10" 82.0" 82.5" 712" 2" TSPAN14" TR" A0.71" 0" 0.01" 1.00" "2216" 1" TSPAN14" CD4"CD14" 0.76" 0" 0.01" 1.00" 2"HD116" 10" 101.2" 101.4" 5439" 1" SLC25A28' CD14" A0.61" 0" 0.22" 1.00" "J_11_57" 11" 58.1" 58.6" 7164" 1" ZFP91" PLA" A0.64" A0.75" 0.02" 0.07" "J_11_59" 11" 61.3" 61.8" 1670" 1" TMEM258" CD4"CD8"CD19" 0.83" 0" 0.04" 1.00" "J_11_65" 11" 65.4" 65.9" 451" 2" CTSW"FIBP" CD4"CD8" A0.73" 0" 0.01" 1.00" 2"HD122" 11" 114.2" 114.6" 268" 3" REXO2"NXPE1"NXPE4" TR"RE" 0" A0.89" 1.00" 0.02" 4"37"HD123" 11" 118.3" 118.8" 8200" 1" TREH" IL" 0" 0.7" 1.00" 0.05" "HD142" 14" 88.2" 88.7" 8940" 1" GPR65" CD14" 0.8" 0.79" 0.01" 0.01" "6353" 1" (GALC)" CD14" A0.52" A0.23" 0.06" 0.06" 4"J_15_40" 15" 41.3" 41.8" 9109" 1" CHP1" IL" 0.62" 0" 0.01" 1.00" "J_16_22" 16" 23.6" 24.1" 2672" 1" PRKCB" CD14" 0" 0.64" 1.00" 0.05" 2"HD150" 16" 28.2" 29.1" 6" 8" TUFM"SBK1"APOBR"SGF29'CLN3'SPNS1" CD4"CD8"CD19"CD14"CD15"IL"TR"RE" 0.81" 0.86" 0.05" 0.03" 4"HD151" 16" 30.4" 31.4" 2673" 1" RNF40" CD15" A0.63" 0" 0.02" 1.00" "1886" 1" ITGAL' CD4"CD8"CD19" 0" 0.74" 1.00" 0.01" 39"HD153" 16" 68.4" 68.9" 1894" 1" ZFP90" CD4"CD8"CD19"CD14"TR" 0" 0.83" 1.00" 0.07" 2"36"HD156" 16" 85.9" 86.1" 3328" 1" IRF8' TR"RE" 0" 0.72" 1.00" 0.01" "HD159" 17" 37.3" 38.3" 37" 5" GSDMB+ORMDL3'PGAP3'(GSDMA)' CD4$CD8$CD19"CD14"IL$TR$RE" A0.98" A0.92" 0.02" 0.01" 2"4"HD161" 17" 40.3" 41.0" 836" 2" STAT3' PLA" 0.67" 0" 0.10" 1.00" "HD164" 18" 67.4" 67.6" 1988" 1" CD226" CD4"CD8"PLA" 0" A0.86" 1.00" 0.01" 2"N_18_76" 18" 76.7" 77.7" 7292" 1" PQLC1" PLA" A0.68" 0" 0.01" 1.00" "HD166" 19" 10.3" 10.7" 9232" 1" (TYK2)" CD14" A0.44" A0.09" 0.10" 0.10" "HD168" 19" 47.1" 47.4" 581" 2" GNG8" CD4" 0" A0.63" 1.00" 0.06" "HD169" 19" 49.0" 49.3" 3128" 1" FUT2+ IL$TR$RE$ A0.95" 0" 0.01" 1.00" 4"J_20_31" 20" 31.1" 31.6" 593" 2" COMMD7" CD14" 0" 0.61" 1.00" 0.01" "J_20_32" 20" 33.6" 34.1" 7" 8" UQCC1" CD19" A0.69" 0" 0.02" 1.00" 2"3369" 1" MMP24AAS1" RE" A0.63" A0.71" 0.03" 0.03" "HD175" 20" 62.2" 62.5" 2322" 1" LIME1' CD4"CD19" A0.86" 0" 0.01" 1.00" 2"HD176" 21" 16.6" 16.9" 9578" 1" NRIP1" CD4" 0" A0.69" 1.00" 0.02" "HD180" 22" 21.7" 22.1" 2130" 1" UBE2L3$ CD4$CD8$CD19$CD14$CD15$IL$TR$RE$ 0.97" 0.92" 0.01" 0.07" 2"4"N_22_41" 22" 41.4" 42.4" 2149" 1" EP300" CD8"CD19"CD15" 0" 0.71" 1.00" 0.02" ""1154"
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Supplementary	note	1:	Genes	with		strong	DAP-EAP	correlation	6	
IL18R1	 encodes	 the	 IL-18r1,	 the	 receptor	 of	 IL-18,	 a	 potent	 proinflammatory	7	 cytokine	governing	host-microorganism	homeostasis	and	is	postulated	to	play	a	8	 role	in	IBD1,2.	However,	IL-18/IL-18r1	precise	contribution	to	the	disease	remains	9	 controversial.	Indeed,	compared	to	wild-type	mice,	Il18-/-	and	Il18r1-/-	full	KO	mice	10	 are	more	susceptible	to	AOM/DSS-induced	colitis	and	polyp	formation3.	However,	11	 targeted	 deletion	 of	 Il18-/-	 and	 Il18r1-/-	 in	 intestinal	 epithelial	 cells	 confers	12	 protection	from	colitis	and	mucosal	damage	in	mice4.	In	human,	several	studies	13	 have	associated	circulating	or	local	IL-18	with	IBD	severity,	suggesting	that	IL-18	14	 could	be	an	effector	cytokine	in	IBD5.		15	
IL6ST	encodes	the	interleukin	6	signal	transducer	protein	(IL6ST),	also	called	IL6	16	 beta,	GP130	or	CD130.	IL6ST	is	a	common	transmenbrane	receptor	for	all	family	17	 members	 of	 IL6	 that	 include	 IL-6,	 IL-11,	 ciliary	 neurotrophic	 factor	 (CNTF),	18	 cardiotrophin-1	(CT-1),	cardiotrophin	 like	cytokine	(CLC),	 leukaemia	 inhibitory	19	 factor	(LIF),	oncostatin	M	(OSM),	neuropoitin	(NPN)	and	interleukin-27	(IL-27)6.	20	 IL6	 family	 members	 /	 IL6ST	 signaling	 pathways	 involve	 the	 activation	 of	 JAK	21	 (Janus	 kinase)	 family	 members,	 leading	 to	 the	 activation	 of	 STAT	 (signal	22	 transducers	and	activators	of	 transcription)	 family,	 as	well	 as	 the	activation	of	23	 MAPK	(mitogen-activated	protein	kinase)	pathway.		These	pathways	are	involved	24	 in	cell	survival,	apoptosis,	differentiation	and	proliferation6.	The	involvement	of	25	 IL6/IL6ST/STAT3	 in	 the	 pathophysiology	 of	 IBD	 is	well	 documented7.	 Indeed,	26	 high	circulating	levels	of	IL6	is	associated	with	increased	severity	of	the	disease7.	27	 T	 cells	 from	 IBD	 patient	 show	 increased	 STAT3	 activation	 with	 increased	28	 expression	of	 IL6ST	and	enhanced	resistance	to	apoptosis8.	A	pilot	clinical	 trial	29	 (phase	 I)	 targeting	 of	 IL6/IL6ST	 pathway	 in	 patients	with	 CD	 has	 shown	 that	30	 blocking	this	pathway	has	effects	similar	to	the	inhibition	of	TNF9,10.		31	
THEMIS	 encodes	 the	 thymocyte-expressed	 molecule	 involved	 in	 selection	32	 (THEMIS),	the	expression	of	which	is	limited	to	lymphoid	tissues.	In	mice,	THEMIS	33	 is	highly	expressed	in	pre-TcR	thymocytes	and	plays	an	important	role	in	T-cell	34	 development	 and	 TCR	 activation	 signaling11,12.	 Its	 expression	 is	 reduced	 in	35	 differentiated	T	lymphocytes12.	THEMIS	deficiency	in	mice	is	associated	with	the	36	
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presence	 of	 higher	 percent	 of	 Treg	 cells,	 with	 reduced	 TCR-mediated	 T	 cell	37	 response,	 increased	 proportion	 of	 memory	 CD4	 and	 CD8	 T	 cells	 and	 reduced	38	 proportions	 of	 naïve-phenotype	 populations12.	 Interestingly,	 all	 these	 T	 cells	39	 associated	 feathers	 are	 implicated	 in	 the	 pathogenesis	 of	 IBD.	 Indeed,	 lamina	40	 propria	T	cells	in	IBD	are	hypo-responsive	to	TCR	stimulation	and	high	number	of	41	 effector	T	cells	are	present	 in	 the	 inflamed	bowel13.	 	As	 for	Treg,	only	moderate	42	 expansion	was	seen	in	intestinal	lesions	of	Crohn’s	patients	suggesting	that	their	43	 suppressive	activity	is	probably	not	sufficient	against	the	overwhelming	effector	44	 T	cells	activity13.	45	
APEH	 encodes	 the	 acylpeptide	 hydrolase	 (APEH)	 enzyme	 that	 contributes	 to	46	 protein	degradation	processes	 in	 concert	with	 the	proteasome.	 It	 catalyzes	 the	47	 removal	of	N-acylated	amino	acids	 from	acetylated	peptides14.	 Its	physiological	48	 role	is	not	well	undertood.		SNPs	in	APEH	gene	hves	been	associated	with	both	CD	49	 and	UC15.	Like	other	ubiquitin	proteasome	systems	(UPS)	such	as	USP40	or	CYLD,	50	 APEH	may	also	regulate	the	NF-kB	pathway.		Under	this	scenario,	an	alteration	of	51	 NF-kB	signaling	may	lead	to	aberrant	immune	response	and	inflammation.		52	
ANKRD55	 encodes	 an	 Ankyrin	 repeat	 domain-containing	 protein	 55	 with	53	 unknown	function.	Ankyrin	repeats	are	composed	of	33-34	aa	and	are	the	most	54	 abundant	motifs	 in	 nature	with	highly	 diverse	 cellular	 functions16.	 SNPs	 at	 the	55	 ANKRD55	locus	have	also	been	associated	with	multiple	sclerosis17	and	RA18.		56	
CISD1	gene	encodes	a	highly	conserved	iron-sulfur	domain-containing	protein	A,	57	 known	as	mitoNEET.	This	 iron-containing	protein	 is	 a	dynamic	 redox-sensitive	58	 molecule	that	serves	an	important	role	in	mitochondrial	functions.	It	participates	59	 in	critical	process	such	as	electron	shuttling	through	the	electron	transport	chain,	60	 regulation	 of	 enzymatic	 activity,	 and	 synthesis	 of	 heme	 and	 iron-sulfur	61	 clusters19,20.	 Deregulation	 of	 iron	metabolism	 and	 associated	 anemia	 has	 been	62	 associated	with	IBD21.	The	role	that	mitoNEET	plays	in	the	etiology	of	IBD	remains	63	 to	be	determined.	64	
CPEB4	gene	encodes	the	cytoplasmic	polyadenylation	element-binding	protein	4	65	 (CEBP4),	which	belongs	to	a	 family	of	proteins	that	bind	mRNAs	and	contain	a	66	 cytoplasmic	polyadenylation	element	(CPE)	in	their	3′-UTR.		Binding	results	in	3′-67	
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poly(A)	 tail	 extension	 and	 translational	 upregulation	 of	 target	 mRNAs.	 Cpeb4	68	 mRNA	is	rhythmically	regulated	in	mouse	liver,	conferring	temporal	translational	69	 regulation.	 	In	the	absence	of	CPEB4,	a	large	number	of	mRNAs	are	transcribed,	70	 but	 remain	 untranslated	 until	 needed22.	 A	 recent	 study,	 using	 knockout	 mice	71	 models,	showed	that	CPEB4	was	required	 for	translation	of	numerous	proteins	72	 involved	in	ER	homeostasis	and	CPEB4	loss	resulted	in	mitochondrial	dysfunction	73	 and	defective	lipid	metabolism,	two	hallmarks	of	ER	stress.	Cpeb4	KO	livers	were	74	 highly	susceptible	to	ER	stress-induced	apoptosis	and	to	development	of	NAFLD23.		75	 In	CD,	reduced	CPEB4	may	also	lead	to	ER	stress	and	mitochondrial	dysfunction.		76	
DOCK7	encodes	dedicator	of	 cytokinesis	7	protein	 (Dock7),	 a	member	of	Dock	77	 proteins	family	and	an	activator	of	Rac	GTPases.	DOCK7	plays	an	important	role	78	 in	axon	outgrowth,	Schwann	cell	migration,	and	axon	myelination24.	Mutation	in	79	 this	gene	in	mice	leads	to	hypopigmentation	suggesting	a	non-redundant	role	in	80	 the	 distribution	 and	 function	 of	 dermal	 and	 follicular	 melanocytes.	 However,	81	 mutant	mice	show	normal	neuronal	function	despite	the	high	expession	of	DOCK7	82	 in	the	developping	brain,	suggesting	redundancy	with	other	Docks25.	The	role	of	83	 DOCK7	in	IBD	and	immune	cells	function	is	totally	unknown.		84	
ERAP2	 gene	 encodes	 an	 endoplasmic	 reticulum	 aminopeptidase	 (ERAP2),	 an	85	 enzyme	 involved	 in	 trimming	 of	 peptides	 for	 MHC-I	 loading.	 Aberrant	 ERAP2	86	 function	could	influence	peptide-HLA-B27	stability,	formation	of	MHC-I	free	heavy	87	 chains	and	ER	stress26,27,28.	SNPs	in	ERAP2	gene	have	been	associated	with	CD29.	88	 Although	 the	underlying	mechanisms	are	not	known,	 it	 is	possible	 that	ERAP2	89	 modification	contributes	to	the	reported	reduction	of	MHCI	on	CD4	T	cells	from	90	 CD	patients30.	ERAP2	modification	may	also	contribute	to	the	epithelial	ER	stress	91	 associated	with	CD	and	UC.		92	
GNA12	 encodes	Guanine	 nucleotide-binding	 protein	 subunit	 alpha-12	 or	G!12,	93	 which	belongs	to	 the	heterotrimeric	G	proteins.	Gα12	 is	 found	 in	tight	 junctions	94	 (TJ)	 where	 it	 interacts	 with	 ZO-131	 and	 plays	 important	 roles	 in	 para-cellular	95	 permeability32,33.	 Gα12	 is	 ubiquitously	 expressed	 and	 interacts,	 upon	 receptor-96	 mediated	 activation,	 with	 certain	 Rho	 guanine	 nucleotide	 exchange	 factors	97	 (RhoGEFs)	which	in	turn	mediate	activation	of	the	small	GTPase	RhoA34.	Intestinal	98	
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permeability	and	barrier	dysfunction	is	a	hallmark	of	CD	and	UC.	Several	studies	99	 reported	changes	in	the	expression	of	several	TJ	proteins	in	both	diseases35.		It	is	100	 conceivable	 that	modifications	 in	 the	Gα12	pool	 leads	 to	 alteration	of	 intestinal	101	 permeability.		Tissue-specific	Gα12-deficient	mice	revealed	important	functions	of	102	 this	 protein	 in	modulating	T	cell	 trafficking	 and	 proliferation,	 as	well	 as	 in	 the	103	 response	 to	 foreign	 and	 self	 antigens36,	 important	 processes	 that	 may	 affect	104	 susceptibility	for	T	cell-mediated	diseases.		105	
GPX1	 encodes	 the	 glutathione	 peroxidase	 1	 (GPX1),	 a	 highly	 abundant	 and	106	 ubiquitously	expressed	cytosolic	enzyme.	Like	all	glutathione	peroxidases	family	107	 members,	GPX1	catalyzes	the	reduction	of	H2O2	by	glutathione	and	consequently,	108	 protects	 cells	 from	 oxidative	 damage.	 In	 IBD,	 it	 is	 believed	 that	 intestinal	 and	109	 colonic	 injuries	and	dysfunction	 is	at	least	partially	due	to	elevation	of	reactive	110	 metabolites	of	oxygen	and	nitrogen37.	Although	the	role	of	GPX1	is	not	known	in	111	 IBD,	deficiency	of	both	GPX1	and	GPX2	in	mice	lead	to	spontaneous	ileo-colitis	and	112	 intestinal	cancer38.	A	protective	role	of	GPX1	and	GPX2	against	oxidative	stress	has	113	 also	 been	 suggested	 by	 studies	 reporting	 elevated	 Gpx1/2	gene	 expression	 in	114	 gastric	mucosa	after	H.	pylori	infection39.	Association	of	the	elevated	expression	of	115	
Gpx1/2	gene	with	tumorigenesis	could	be	due	to	its	anti-apoptotic	activity40.		116	
GSDMB	encodes	Gasdermin-B	protein	(GSDMB)	the	 function	of	which	 is	 largely	117	 unknown.	 The	 expression	 of	 GSDMB	 has	 been	 associated	 with	 differentiated	118	 epithelial	 cells	 and	 with	 regions	 containing	 proliferating	 cells	 or	 stem	 cells,	119	 respectively,	of	the	esophagus	and	the	gastric	mucosa41,42.	120	
JAZF1,	also	known	as	TIP27,	encodes	a	transcriptional	repressor	of	NR2C2,	also	121	 known	 as	 TAK1	 or	 TR476.	 Mice	 deficient	 in	 NR2C2	 show	 low	 IGF1	 serum	122	 concentrations	and	perinatal	and	early	postnatal	hypoglycemia,	as	well	as	growth	123	 retardation77.	JAZF1	also	affects	variation	in	human	height78.	SNPs	in	JAZ1F	have	124	 been	associated	with	type	II	diabetes79,	prostate80	and	endometrial	cancer81	and	125	 with	 systemic	 lupus	 erythematosus82.	 However,	 the	 role	 of	 JAZF1	 in	 immune	126	 response	and	autoimmunity	remains	to	be	elucidated.		127	
LSP1	encodes	a	leukocyte-specific	protein	1	(LSP1),	a	Ca2+-activated,	intracellular	128	
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filamentous	 actin-binding	 protein	 that	 interacts	 with	 the	 cytoskeleton	 and	 is	129	 expressed	in	hematopoietic	lineage	and	in	endothelial	cells70.	Evidence	from	mice	130	 model	studies	suggest	 that	LSP1	plays	a	negative	regulatory	role	on	neutrophil	131	 and	T	cell	migration71,72.	A	recent	study	identified	a	novel	LSP1	deletion	variant	132	 for	RA	susceptibility	through	CNV	GWAS73.	The	copy	number	of	LSP1	was	found	133	 to	be	significantly	lower	in	RA	patients	and	was	associated	with	increased	T	cell	134	 migration73.	We	found	a	positive	correlation	of	LSP1	expression	(in	CD14+	cells)	135	 with	 UC,	 but	 not	with	 CD.	 UC,	 as	well	 as	 CD,	 is	 characterized	 by	 an	 increased	136	 infiltration	of	immune	cells	in	inflamed	tissues.	Our	finding	is	therefore	surprising	137	 if	 we	 consider	 the	 concept	 of	 an	 association	 between	 increased	 cell	migration	138	 with	LSP1	CNVs	and	LSP1	insufficiency.	It	is	possible	that	LSP1	plays	an	additional,	139	 yet	unknown	role	in	monocytes.	On	the	other	hand,	if	LSP1	participates	actively	in	140	 the	 cross-talk	 between	 leukocytes	 and	 endothelial	 cells	 during	 leukocyte	141	 transmigration,	 the	 physiological	 differences	 in	 microvasculature	 and	 the	142	 integrins	 involved	 may	 dictate	 organ-specific	 roles	 for	 LSP1	 in	 leukocyte	143	 recruitment	into	the	inflammatory	sites.	144	
NXPE1:	 Encodes	 Neuroexophilin	 and	 PC-esterase	 domain	 family	 member	 1	145	 (NXPE1).	 A	 human	 gastointestinal	 tract	 (GIT)	 specific	 transcriptome	 and	146	 proteome	study	validate	 the	expression	pattern	of	 this	gene	and	protein	 in	 the	147	 intestine	 74.	 NXPE1	was	 recently	 identified	 as	 a	 novel	 target	 gene	 for	 IBD-148	 associated	variants75.		Its	function	remains	largely	unknown.		149	
ORMDL3	 encodes	 ORM1-like	 protein	 3,	 a	 negative	 regulator	 of	 sphingolipid	150	 synthesis	and	a	regulator	of	endoplasmic	reticulum-mediated	calcium	signaling45.	151	 ORMDL3	is	involved	in	the	regulation	of	eosinophil	and	T	cell	functios46,47.	It	also	152	 facilitate	 B	 cells	 survival	 and	 regulates	 autophagy	 through	 the	 ATF6	 signaling	153	 pathway48.	Genetic	variants	regulating	ORMDL3	expression	have	been	associated	154	 with	susceptibility	to	ashma49,	T1D50,	atherosclerosis51,	ankylosing	spondylitis52	155	 and	 IBD53.	ORMDL3	might	be	associated	with	IBDs	and	other	autoimmune	and	156	 inflammatory	diseases	by	activating	ERS,	inducing	autophagy	and/or	promoting	157	 immune	cells	activation.			158	
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REXO2	encodes	an	oligoribonuclease	protein.		Its	depletion,	using	RNAi,	causes	a	159	 significant	decrease	of	mtDNA	and	mtRNA	and	 impaired	de	novo	mitochondrial	160	 protein	synthesis83.	REXO2’s	function	remains	unknown	but	it	may	be	involved	in	161	 the	well	documented	mitochondrial	defects	associated	with	IBD84.		162	
RNASET2	 is	 the	 only	 RNase	 T2	 family	 member	 in	 humans	 and	 is	 potentially	163	 involved	in	the	inhibition	of	tumorigenesis,	metastasis	and	angiogenesis85,86.	Loss-164	 of-function	 of	 RNASET2	 protects	 fibroblasts	 from	 oxidative	 stress89	 while	 its	165	 overexpression	 in	 melanocytes	 and	 keratinocytes	 sensitizes	 these	 cells	 to	166	 oxidative-stress-induced	 apoptosis90.	 Interestingly,	 CD	 is	 characterized	 by	 an	167	 impaired	immune	cells	apoptosis	associated	with	elevated	H2O2	in	PBMC	during	168	 the	active	phase	of	the	disease91.	Although	speculative,	it	is	possible	that	reduced	169	
RNASET2	contributes	to	the	altered	oxidative	stress	in	CD.	 170	
SKAP2	encodes	the	Src	kinase-associated	phosphoprotein	2	(Skap2),	a	cytosolic	171	 adaptor	 protein	 expressed	 in	 a	 variety	 of	 cell	 types	 including	 hematopoietic	172	 cells54,55,56.	 Skap2	 has	 been	 implicated	 in	 cell	 adhesion	 through	 association	 to	173	 integrins	and	cytoplasmic	actin55,	and	is	required	for	global	actin	reorganization.	174	 It	interacts	with	different	molecules	implicated	in	integrin	signaling	events54,56,57.	175	 Loss	 of	 Skap2	 in	 mice	 results	 in	 reduced	 inflammation	 in	 experimental	176	 autoimmune	encephalomyelitis	as	well	as	defects	in	macrophage	migration	into	177	 tumor	 metastasis,	 suggesting	 a	 physiologically	 important	 role	 of	 Skap2	 for	178	 leukocyte	recruitment	in	vivo55,58.		179	
UBE2L3	gene	encodes	an	atypical	Ubiquitin	E2	Conjugase	(UBE2L3)	the	role	of	180	 which	has	been	recently	uncovered.	It	is	an	indirect	human	and	mouse	Caspase-1	181	 target	and	plays	an	important	role	in	the	maturation	of	IL-1β.	UBE2L3	depletion	182	 in	 mice	 increases	 pro-IL-1β	 levels	 and	 mature-IL-1β	 secretion	 by	183	 inflammasomes61.	Several	GWAS	identified	polymorphisms	in	the	genomic	locus	184	 of	UBE2L3	 that	 are	 associated	 with	 multiple	 autoimmune	 diseases62	 including	185	 CD29.	 Decreased	 secretion	 of	 the	 inflammasome	 cytokine	 IL-1β	 was	 noted	 in	186	 monocytes	of	Crohn’s	disease	patients63.	It	is	therefore	tempting	to	speculate	that	187	
UBE2L3	contributes	to	disease	at	least	partially	by	modulating	IL-1β	secretion.		188	
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Supplementary	Table	2	214	
	215	
Tissue	 Nr	of	samples	 Nr	of	probes	 Nr	of	PCs	CD4	 303	 13,466	 38	CD8	 294	 13,317	 35	CD19	 282	 12,648	 40	CD14	 286	 13,170	 36	CD15	 289	 11,069	 27	PLA	 251	 6,565	 23	IL	 200	 15,401	 59	TR	 271	 15,082	 50	RE	 267	 14,844	 53		216	 Number	of	usable	samples,	probes	and	PC	for	each	tissue	type.	217	 	 	218	
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Supplementary	Table	3		219	
	220	
Tissue	 Nr	of	probes	 FDR≤0.25	 FDR≤0.10	 FDR≤0.05	 FDR≤0.01	CD4	 13,466	 7,417	 4,957	 4,176	 3,247	CD8	 13,317	 6,760	 4,309	 3,599	 2,779	CD19	 12,648	 4,984	 3,138	 2,549	 1,953	CD14	 13,170	 7,118	 4,728	 3,961	 3,106	CD15	 11,069	 3,611	 2,396	 1,983	 1,512	PLA	 6,565	 1,404	 996	 854	 653	IL	 15,401	 2,769	 1,728	 1,426	 1,031	TR	 15,082	 5,183	 3,391	 2,807	 2,160	RE	 14,844	 4,180	 2,726	 2,295	 1,731		221	 Number	 of	 cis-eQTL	 found	 in	 the	 nine	 analyzed	 cell	 types	 for	 different	 FDR	222	 thresholds	(see	also	Suppl.	Figure	7).	 	223	
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Supplementary Figures 224	 	225	
1. Supplementary Figure 1 226	
	227	 Absolute	values	of	ϑ	for	pairs	of	eQTL	driven	by	distinct	regulatory	variants	(blue),	228	 and	for	pairs	of	eQTL	driven	by	the	same	regulatory	variants	(red).		The	first	(blue)	229	 were	 obtained	 by	 confronting	 real	 cis-eQTL	 with	 in	 silico	 simulated	 eQTL	230	 explaining	the	same	variance	as	the	real	eQTL	but	driven	by	a	randomly	chosen	231	 SNPs	 in	 a	 2Mb	 window	 centered	 around	 the	 probe.	 	 The	 second	 (red)	 were	232	 obtained	 by	 confronting	 eQTL	 obtained	 by	 reanalyzing	 two	mutually	 exclusive	233	 halves	of	the	CEDAR	population	separately	in	a	region	harboring	a	real	cis-eQTL.		234	 It	can	be	seen	that	ϑ	very	effectively	discriminates	between	pairs	of	eQTL	driven	235	 by	 distinct	 (blue)	 vs	 the	 same	 (red)	 regulatory	 variants.	 	 By	 choosing	 0.6	 as	236	 threshold	 value	 for	 ϑ,	 one	 captures	 most	 red	 pairs	 (~88%)	 with	 minimum	237	 contamination	of	blue	pairs	 (~5%).	 	 Log(1/p):	 eQTL	are	sorted	by	 the	smallest	238	 log(1/p)	value	of	the	two	eQTL	being	compared.		239	 	 	240	
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2. Supplementary Figure 2	241	 	242	
	243	 Graphical	representation	(using	Cytoscape1)	of	269	cis	acting	regulatory	modules	244	 (cRM)	including	at	least	three	genes	(see	Suppl.	Table	2).		Every	node	corresponds	245	 to	a	cis-eQTL	involving	a	specific	gene-tissue	combination.		Edges	connect	pairs	of	246	 cis-eQTL	for	which	|"| ≥	0.6.	247	 1. Shannon,	P.	et	al.	Genome	Res.	13,	2498-2504	(2003).	248	 	 	249	
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3. Supplementary Figure 3 250	 	251	



































































































Momozawa	et	al.	Supplemental	material		 	 Page 15 of 32	
4. Supplementary Figure 4 256	 	257	
	258	 Across	the	entire	genome,	the	proportion	of	multigenic	cRM	was	shown	to	be	259	 0.10	(see	also	main	text,	figure	1B).		Amongst	DAP	matching	cRM	(mapping	to	260	 63	of	200	studied	IBD	risk	loci;	main	text	Table	1)	this	proportion	was	shown	261	 to	 be	 0.33,	 hence	 a	 highly	 significant	 enrichment.	 	 To	 ensure	 that	 this	262	 enrichment	was	not	only	due	to	the	fact	that	matching	between	DAP	and	EAP	263	 was	de	facto	tested	multiple	times	for	multigenic	cRM	and	only	once	for	other	264	 cRM,	we	only	tested	one	randomly	sampled	EAP	per	cRM	(whether	monogenic	265	 or	multigenic).		This	was	repeated	100,000	times	and	yielded	the	distribution	266	 of	the	proportion	of	multigenic	cRM	amongst	DAP	matching	cRM	shown	above.		267	 The	average	was	0.22,	and	we	never	observed	values	≤ 0.11,	i.e.	the	genome-268	 wide	average.	269	 	 	270	
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5. Supplementary Figure 5 271	
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6. Supplemental Figure 6 292	 	293	
	294	 Comparison	of	the	alternative	allele	frequency	for	1,781	variants	observed	in	this	295	 study	and	in	55,860	non-Finnish	European	samples	from	the	GNMAD	study.	296	 	 	297	
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8. Supplementary Figure 8 318	 	319	
	320	 Effect	of	increasing	sample	size	on	the	log(1/p)	values	of	a	one-sided	burden	321	 test	 assuming	 that	 the	 effects	 observed	 for	 TYK2	 (blue),	 ERAP2	 (red)	 and	322	
CARD9	(green)	observed	in	this	study	are	real	unbiased.		The	dotted	horizontal	323	 black	 line	 corresponds	 to	 an	 hypothetical	 experiment-wide	 significance	324	 threshold	 assuming	 the	 realization	 of	 200	 independent	 tests	 (targeting	 for	325	 instance	100-200	genes	selected	on	the	basis	of	coincident	DAP-EAP	patterns).		326	 The	plain	horizontal	black	line	corresponds	to	an	hypothetical	genome-wide	327	 significance	 threshold	assuming	 the	realization	of	20,000	 independent	 tests	328	 (targeting	all	genes).		It	can	be	seen	that	an	at	least	4-fold	increase	in	sample	329	 size	is	needed	to	achieve	significance	in	the	first	scenario	and	at	least	7-fold	330	 increase	in	the	second	scenario.				331	 	 	332	
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9. Supplementary Figure 9 333	 	334	
	335	 Proportion	of	usable	probes	with	cis-eQTL	at	various	levels	of	FDR	in	the	nine	336	 analyzed	cell	types.	337	 	 	338	
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10. Supplementary Figure 10 339	 	340	
341	 Graphical	 illustration	 of	 the	 relationship	 between	 rw,	 rws	 and	" .	 	 The	 penalty	342	 function	 applied	 to	 rws	 to	 generate	" ,	 corresponds	 to	 --./01(3405) ..	 The	 graph	 is	343	 shown	for	k	=	30	and	T=0.3,	the	values	used	in	this	study.	344	 The	point	here	is	that	if	two	association	patterns	are	“similar”	(driven	by	the	same	345	 variants),	 the	 correlation	 (rw	 in	 Suppl.	 Methods)	 between	 –log(1/p)	 values	 is	346	 expected	 to	 be	 positive.	 	 	 If	 two	 association	 patterns	 are	 different	 (driven	 by	347	 distinct	variants)	they	may	generate	strong	negative	correlations	(rw).		The	first	348	 part	of	the	method	aims	at	weeding	out	such	instances	(negative	rw).		One	way	to	349	 do	 this	 is	 to	 choose	 a	 simple	 threshold	 value	 for	 rw.	 	 We	 herein	 propose	 an	350	 approach	that	offers	more	flexibility:	it	generates	a	penalty	that	increases	when	351	 the	correlation	decreases	with	an	adaptable	rate.	 	As	shown	in	Suppl.	Fig.	8,	the	352	 values	of	k=30	and	T=0.3	essentially	correspond	to	a	threshold	value	of	0.3.	 	As	353	 can	 also	 be	 seen	 from	 Suppl.	 Fig.	 8,	 there	 is	 (as	 expected)	 a	 strong	 linear	354	 relationship	with	slope	1	between	rw	and	|678|	(and	hence	between	rw	and	|"|	for	355	 pairs	with	rw	>	0.3).		Because	we	subsequently	use	a	threshold	value	|"| ≥ 0.6,	the	356	 choice	T	has	very	little	impact	on	the	outcome	unless	one	approaches	0.6.	357	 	358	 	359	360	
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11. Supplementary Figure 11 361	 	362	 	363	 	364	 	365	 	366	 	367	 	368	 	369	 	370	 	371	 	372	 	373	 	374	 Schematic	representation	of	the	key	features	of	the	implemented	“burden	test”.	375	 The	analysis	is	restricted	to	rare	variants	with	MAF	<	0.005	to	ensure	that	the	new	376	 signal	is	independent	of	the	one	that	lead	to	the	identification	of	the	corresponding	377	 risk	loci	by	GWAS	(based	on	common	and	low	frequency	variants).		Variants	can	378	 be	sorted	in	(i)	singletons	(i.e.	observed	only	ones	in	the	analyzed	samples),	(ii)	379	 perfect	(i.e.	observed	more	than	ones	in	the	sample	but	perfectly	associated	with	380	 disease	status),	and	(iii)	other	(i.e.	observed	more	than	ones	in	the	sample	in	both	381	 cases	and	controls).			382	 We	 test	 two	 hypotheses.	 	 The	 first	 assumes	 that	 disruptive	 variants	 are	 either	383	 enriched	in	cases	or	in	controls	as	a	function	of	the	sign	of	the	correlation	between	384	 DAP	and	EAP	(if	decreased	expression	is	associated	with	increased	risk,	disruptive	385	 “risk”	 variants	 are	 expected	 to	 be	 enriched	 in	 cases;	 if	 increased	 expression	 is	386	 associated	with	increased	risk,	disruptive	“protective”	variants	are	expected	to	be	387	 enriched	in	controls).			The	test	is	implemented	with	CAST	and	in	essence	performs	388	 a	one-sided	test	of	independence	(what	is	the	probability	to	observe	the	excess	of	389	 disruptive	variants	in	cases	(respectively	controls)	by	chance	alone?).	The	second	390	 hypothesis	tests	whether	the	distribution	of	the	variants	in	cases	and	controls	is	391	 characterized	by	too	many	variants	that	tend	to	be	overrepresented	either	in	cases	392	 or	in	controls.	Thus,	this	hypothesis	allows	some	disruptive	variants	to	increase	393	 risk	and	others	to	be	protective.		This	hypothesis	does	not	use	information	from	394	 singletons.		Testing	this	hypothesis	is	implemented	with	SKAT.	It	can	be	seen	in	395	 simplified	form	as	combining	the	p-values	(from	a	test	of	independence)	across	396	 variants	 (without	 considering	 the	 sign	of	 the	effect)	using	 for	 instance	Fisher’s	397	 method.						398	399	
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12.  Supplementary Figure 12 400	
401	
	402	 	403	 Distribution	of	permutation-based	–log(p)	values	obtained	for	68	analyzed	genes	404	 with	synonymous	variants	using	CAST	(A),	and	SKAT	(B),	indicating	that	CAST	is	405	 conservative	 (,	 while	 SKAT	 is	 too	 permissive	 ( :;< = 1.73) .	 	 The	 68	 genes	406	 correspond	to	the	47	genes	reported	in	this	study,	plus	21	genes	sequenced	in	the	407	 same	cohort	as	part	of	another	study.	408	 	 	409	
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